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ABSTRACT
ASSESSMENT OF THE FATE OF CRYPTOSPORIDIUM PARVUM, GIARDIA
LAMBLIA AND ASCARIS LUMBRICOIDES IN CLASS A COMPOSTING AND
CLASS B LIME STABILIZATION BIOSOLIDS TREATMENT PROCESSES
by
Christine L. Bean
University of New Hampshire, December, 2003

The management of biosolids in the United States has become an issue of public
health concern in regard to disposal. Congress created the Clean Water Act in 1972 to
protect waters in the United States and as a result, no longer can human waste be dumped
into oceans or rivers. Means of disposal of biosolids are focused on land application
today. The practice of land application takes into consideration the classification of the
biosolids material and management practices to control access to and growth of crops on
the land. Biosolids are classified as either Class A or Class B depending on which
process was used to produce the material. Class A biosolids are “virtually” pathogen free
and Class B have pathogens present in reduced numbers.

The only parasite indicator organism that is required by the Environmental
Protection Agency’s Part 503 Rule to screen for in biosolids is Ascaris lumbricoides.
Protozoans including Cryptosporidium parvum and Giardia lamblia were not considered

xi
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human pathogens when the Part 503 rule was written, but are present in biosolids
materials using the recovery methods developed in this project. Through the use of these
methods, the protozoa were found to be at least as prevalent as Ascaris lumbricoides. A.
lumbricoides cannot be used as an indicator of the presence of all parasites since it has a
variable geographic distribution in the United States.

Two biosolids treatment methods were assessed to determine the persistence of
parasites in Class B lime stabilization and Class A composting. Results of the lime
stabilization procedure show evidence that this method is effective in reducing bacteria
concentration, but that the parasites persisted throughout the treatment process. The
Class A treatment process, on the other hand, was effective in reducing C. parvum, G.
lamblia and A. lumbricoides.

The Class A composting process involves heat inactivation and is a method that
has shown to reduce pathogens more effectively than Class B treatments where no heat is
required.

The ability to demonstrate that pathogens are reduced after a particular

treatment is dependent on the availability of efficient recovery methods and
viability/infectivity assays.

xii
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CHAPTER ONE
AN OVERVIEW OF LEGISLATION AND PATHOGEN STANDARDS
FOR THE TREATMENT AND LAND APPLICATION OF BIOSOLIDS

INTRODUCTION
Clean W ater Act
In 1972, Congress enacted the first comprehensive national clean water legislation
in response to growing public concern for serious and widespread water pollution by
amending the Federal Water Pollution Control Act of 1948 and creating the Clean Water
Act. The Clean Water Act is the primary federal law that protects waters in the United
States including lakes, rivers and coastal areas from pollution and is implemented by a
joint effort of the Environmental Protection Agency (EPA) and individual states. Today,
the quality of our waters has improved as a result of the implementation of pollution
control programs established by this Act. One of the national goals of this legislation is to
eliminate the discharge of pollutants like sewage into waters. In addition to improving the
nation’s water quality standards, the legislation provided billions of dollars for
construction of sewage treatment plants. In 1972, sewage treatment plants served only 85
million people whereas today modem wastewater facilities serve 173 million people
(NRC, 2002).

1
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Biosolids
As a result of the Clean Water Act, the generation of biosolids has increased to
over thirteen million tons per year in the United States (EPA, 1999a). The term biosolids
is used to refer to domestic wastewater sludge that meets EPA standards for use as a
fertilizer or soil conditioner. The term "sludge" was replaced with the term biosolids
after a wide spread campaign started in 1991 to clarify terminology.
There are several alternatives for disposal of these biosolids, which include
incineration, surface disposal in landfills, and land application. Incineration and
landfilling of biosolids pose environmental and economic costs. Incineration of biosolids
is the burning at high temperatures in an enclosed device. Concern over the production
of dioxins from these biosolids materials has resulted in a movement away from
incineration (NIOSH, 2000). Surface disposal occurs when biosolids are placed on an
area of land for final disposal. Examples of sites for surface disposal include landfills,
lagoons and waste piles. Land application is the application of biosolids to land to either
condition the soil or to fertilize crops or other vegetation grown in the soil. Techniques
to perform land application include spraying or spreading on the soil surface or tilling
into the soil after being surface applied. Land application has increased from 33% of
biosolids generated to 60% from 1988 to 1998 and has become the focus for disposal of
biosolids (EPA, 1999A).

2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Land Application
The practice of land application to dispose of and recycle biosolids has
advantages and disadvantages. Benefits of land application include the effective recycling
of nutrients like nitrogen and phosphorus and organic matter, which improves the water
holding capacity of the land on which it has been applied. Reductions have also been seen
in the cost to farms for fertilizer as well the use of inorganic fertilizers. Land application
is considered a cost-effective means of disposal.
The risks associated with land application include the potential for pathogen and
heavy metal exposure. Municipal wastewater may contain four major types of human
pathogenic organisms including viruses, protozoa, bacteria and helminthes (Table 1).

3
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Table 1
Principal Pathogens of Concern in Domestic Sludge and Sewage Sludge Considered
in Establishing the Part 503 Rule

PROTOZOA

BACTERIA
Salmonella sp.
Shigella sp.
Yersinia sp. Vibrio cholerae
Campylobacterjejuni
Escherichiae coli

Cryptosporidium
Entamoeba histolytica
Giardia lamblia
Balantidium coli
Toxoplasma gondii

HELMINTH WORMS

ENTERIC VIRUSES

Ascaris lumbricoides
Ascaris suum
Trichuris trichuria
Toxocara canis
Taenia saginata
Taenia solium
Necator americanus
Hymenolepsis nana

Hepatitis A virus
Adenovirus
Norwalk virus
Caliciviruses
Rotaviruses
Enteroviruses
Polioviruses
Coxsackieviruses
Echoviruses
Reoviruses
Astroviruses

There is also a risk of exposure to heavy metals such as lead, cadmium and mercury
(NRC, 2002). The long-term effects of land application are not understood and the
cumulative loading issues for heavy metals are still being addressed. Another
disadvantage

is

the

negative

public perception of land application. There

4
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continues to be a need for public education to overcome this issue. Potential effects on
ground water quality need to be considered when biosolids are stockpiled in large
amounts for periods of time. Runoff from these stockpiles also has the potential for
contaminating surface waters.

Environmental Protection Agency's Part 503 Biosolids Rule
When the Clean Water Act was again amended in 1987, the EPA Part 503
Biosolids Rule was written which established standards for the use or disposal of sewage
sludge (EPA, 1996). The intention of the Part 503 Rule was to protect public health and
the environment from any adverse effects of pollutants that may be present in sludge.
The potential risk posed by pollutants in sewage sludge to affect public health and the
environment through a number of different routes of exposure was assessed.
Transmission routes evaluated included inhalation, direct ingestion of soil fertilized with
sewage sludge, direct dermal contact with sewage sludge, consumption of crops grown
on this soil, and contamination of drinking water or surface water with biosolids. The
Part 503 Rule identified the potential pathogens present using the best scientific
practices at that time and because it has not been revised, newly emerging pathogens
since the mid-1980’s have not been addressed or considered in the Part 503 Rule.

Class A and Class Biosolids
The Part 503 pathogen reduction alternatives ensure that pathogen levels in
biosolids are reduced to levels considered safe for the biosolids to be land applied.
Criteria were developed to classify biosolids as Class A or Class B with respect to the

5
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level of pathogens present. A designation of Class A is used when the pathogen
Salmonella sp., enteric viruses, viable helminth ova and fecal coliforms are below
detectable levels. These levels are less than 3 Most Probable Number (MPN) per 4
grams (g) of total solids for Salmonella sp., less than 1 plaque- forming unit per 4 g total
solids for enteric viruses, less than 1 viable helminth ovum per 4 g total solids and less
than 1,000 MPN per gram for fecal coliforms (EPA, 1999a)(EPA, 1999b). Class A
biosolids are therefore considered “virtually” pathogen free because none of the above
listed pathogens are detectable.
The Class B designation is given to those biosolids when pathogens are
detectable, but have been reduced to levels that do not pose a threat to public health and
the environment as long as actions are taken to prevent exposure to the biosolids after
their use or disposal. The land application restrictions allow natural processes like
ultraviolet light and air-drying to further reduce pathogens in the biosolids before the
public has access to the site and through these practices it is thought to protect public
health to the same extent as the Class A requirements.
Because Class A biosolids are virtually pathogen-free, uses include public sites
such as golf courses and the use on foods such as root crops. Class B biosolids have
more site restrictions which include such stipulations as animals shall not graze on the
land for 30 days after application and public access to land with a high potential for
public exposure shall be restricted for 1 year after application. Additionally, food crops
with harvested parts that touch the biosolids/soil mixture and are totally above the land
surface shall not be harvested for 14 months after application (NRC, 2002).
The designation Class A or Class B can be achieved by the use of a treatment

6
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process to meet the pathogen reduction requirements. Examples of accepted treatment
processes for meeting the Class A pathogen requirement are thermally treating
biosolids, treating with high pH temperature process or composting. Class B biosolids
are a result of the application of a Process to Significantly Reduce Pathogens (PSRP)
(NRC, 2002), which includes aerobic digestion, anaerobic digestion and lime
stabilization. The Part 503 regulations established a requirement for the frequency of
monitoring for pathogens based on the amount of sludge used or disposed.

For

example, if equal to or greater than 15,000 metric tons of sewage is used or disposed of
per year, monthly monitoring is required whereas if less than 290 metric tons per year
are used or disposed of, monitoring must be performed only one time during that year
(EPA, 1999a) (EPA 1999b).

Pathogens
Pathogens that propagate in the enteric system of humans are excreted in feces
and therefore pose a risk to public health. The level of the four major types of human
pathogens in sewage; bacteria, viruses, protozoa and helminthes, varies depending on
both the overall health status of the local community and the reduction achieved by the
treatment process utilized. Pathogen species and density in wastewater will also vary with
the time of year as many of these organisms show seasonal distribution.
Exposure to an infectious agent and the resulting development of disease
depends on the infectious dose. Ascaris lumbricoides has an infectious dose of one
viable helminth ova (VHO). Cryptosporidium parvum has been shown to have an
infectious dose as low as thirty oocysts (Garcia, 2002). Possible routes of direct

7

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

exposure to pathogens include contact when handling soil from home gardens where
biosolids have been applied or by inhaling airborne microbes. Examples of indirect
exposure routes include consumption of water or food contaminated with pathogens.
The study of these exposure routes led to the use of site restrictions imposed by the Part
503 Rule.
The Part 503 Rule also requires direct monitoring of viable helminth ova,
specifically Ascaris ova, as an indicator for several other helminth species such as
Trichuris and Hymenolepsis. Routine monitoring for all parasites is unrealistic due to
cost and lack of methods for all potential pathogens.

Therefore, monitoring for

indicator organisms has become a routine part of monitoring programs (NRC, 2002). At
the time the Part 503 Rule was written, work by Yanko et al in Los Angeles (Yanko,
1988) showed that Ascaris ova were the hardiest of pathogens. On soil surfaces,
helminth ova were found to die off after four months, but up to fifty percent of the ova
might still persist after four months if the ova were within the soil matrix (Yanko et al.,
1988). For this reason, Ascaris was chosen as the indicator organism for treatment
effectiveness for all helminthes.

Ascaris lumbricoides
Life Cycle.
The adult nematode, Ascaris lumbricoides, measures 20-35 cm long (female)
and 15-31 cm long (male). Adults mature and mate in the intestine of humans and
produce eggs, which are passed in stool. The adult female may generate nearly 300,000
eggs during her life span (Garcia, 2002). Fertilized and unfertilized eggs are passed

8
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in human feces. Fertilized eggs become infective within two weeks in warm, moist soil
and may remain viable for months to years (Garcia, 2002). The eggs are 75 um long and
50 um wide and have a thick, albuminous coat. Unfertilized eggs are larger, 90 um long,
and have a minimal outer coat.
Human infection is acquired by ingesting fertilized eggs from soil. Once
ingested, the eggs hatch in the stomach and duodenum and larvae penetrate the intestine
wall. Larvae are carried by the circulatory system to the heart and then migrate into the
pulmonary system where they are filtered out by capillaries. Larvae break into the
alveoli of the lung and migrate to the trachea and pharynx where they are coughed up
and swallowed to continue the autoinfective cycle. It takes eight to twelve weeks to
complete the cycle from egg ingestion to egg passage from the adult female.

Clinical Disease and Treatment.
Symptoms of infection vary depending on what stage of the life cycle the host is
experiencing. Migration of larvae through lung tissue may cause early symptoms of
pneumonitis. Tissue reactions and increased eosinophil counts may also occur with
reinfection and larval migration. Ascaris pneumonitis results in allergic reactions and
symptoms of dry cough and fever suggestive of a viral infection. Sputum at this stage
may contain larvae.
Infections with low numbers of adult worms may show no symptoms and
symptoms occur only when the number of adults in the intestine becomes large. Adult
worms may migrate and cause intestinal blockage, enter the bile duct; liver and even
migrate out of the body through the anus, mouth and/or nose (Garcia, 2002). The

9
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adults may carry other pathogens with them like fecal coliforms and cause severe
systemic infections especially in immunocompromised patients. In young children,
malnutrition may also occur.
Antihelmintic drugs like mebendazole and albendazole are available to eliminate
the adult worms although these drugs are not effective against tissue larval stages.
Surgery has been indicated when extraintestinal body sites are involved.

Epidemiology and Prevention.
Ascaris lumbricoides is second only to the parasite pinworm, Enterobius
vermicularis, in prevalence worldwide (WHO, 1986). It is more prevalent in warm,
moist climates like the southeastern part of the United States, but it can survive in
temperate zones like the northeast. It is unclear exactly how prevalent Ascaris infection
is in the United States since the disease is not reportable to state public health
departments or the Centers for Disease Control. Primary prevention to control Ascaris
infection is proper sanitation to prevent the contamination of soil with sewage. Once
ova are deposited in soil, there is no way to kill them and they may exist as a public
health risk for months to years (Garcia, 2002). The use of human feces as fertilizer has
been recognized as a transmission route and is evidence that the land application of
biosolids could also pose a risk.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Protozoa
No monitoring for protozoans is currently required in the EPA regulations, even
though organisms such as Cryptosporidium parvum and Giardia lamblia have been
identified as pathogens of concern in municipal wastewater and sewage sludge. There
may be a significant risk associated with Giardia lamblia and land application of
biosolids as more than 900 cysts per gram wet weight have been found in anaerobically
digested biosolids (NRC, 2002). Even after composting and storage of biosolids for
more than one year, the cyst levels remained high and cysts survived over twelve weeks
in the soil environment. Raw sewage samples examined in the County Sanitation
Districts of Los Angeles County contained an average of 2.5 x 106 Giardia cysts/100 L
(Yanko, 1988).
At the time the Part 503 Rule was written, Cryptosporidium parvum had not been
identified as a human pathogen and was still considered a veterinary pathogen. In one
study by Rose et al (1991), Cryptosporidium oocysts were detected in 17% of 36
finished drinking water samples collected from various areas of the United States. These
protozoa and other newly emerging organisms such as Microsporidia sp., which cause
disease in humans, must be considered as potential public health risks especially since
their small size may allow them to move more easily through soils into water supplies.
Cryptosporidium parvum oocysts and Giardia lamblia cysts are highly resistant to
numerous disinfectants and environmental pressures and survive for several months
outside the host (Garcia, 2002) (NRC, 2002).
The current Part 503 regulations require that only VHO of Ascaris be screened
for as an indicator of parasite removal and treatment

effectiveness.

11
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There

are

geographic differences in the prevalence of Ascaris in the United States. When
biosolids samples are tested for VHO and Ascaris ova are absent, it cannot be
concluded that no protozoans are present in the sample since it is not clear whether
Ascaris is an appropriate indicator of other protozoans. If no Ascaris is present in sludge
prior to processing into biosolids, Ascaris cannot act as a measure of treatment
effectiveness. One goal of this research is to assess the prevalence of Cryptosporidium
parvum, Giardia lamblia and Ascaris lumbricoides in biosolids samples from sites
around the United States. Cryptosporidium parvum and Giardia lamblia are commonly
found in surface water (NRC, 2002). The ubiquitous occurrence of these two protozoans
in water, and as a consequence in the general population (Garcia, 2002), makes these
parasites potential candidates for assessing the fate of protozoans in biosolids treatment
processes. Published data document high levels of each protozoan in treated effluents
and in raw sewage (Yanko, 1988).
Cryptosporidium parvum
Life Cycle
Cryptosporidium parvum is an intestinal coccidian, protozoan parasite that has
emerged as an important cause of diarrhea in humans and animals. The developmental
stages of the parasite occur intracellularly within a vacuole of the host cell and
multiplication does not occur outside the host cell. The vacuole is located at the
microvillous surface of the host cell. Oocysts undergo sporogony while in the host cell
and are immediately infective when passed in feces. Some oocysts, instead of forming
the thick-walled, environmentally resistant form, develop into thin-walled autoinfective
forms. The autoinfective oocyst contains four sporozoites surrounded by a single

12
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membrane, which ruptures when the oocyst is released from the host cell. The released
sporozoites invade the microvillous region of other intestinal cells (Garcia, 2002).
Sporozoites are motile and adhere to and invade epithelial cells lining the gastrointestinal
tract. Invasion involves molecules discharged from the parasite organelles found in the
apical end of the sporozoite. After attachment and discharge of the contents of organelles,
microvilli are disrupted and Cryptosporidium enters the host cell. The host cell
membrane is enveloped around the organism as it enters the cell. Intracellularly, the
parasite is in its vacuole and is separated from the host cell cytoplasm where it replicates
into eight merozoites. The merozoites rupture out of the host cell and infect other cells
and complete the asexual stage of the life cycle. Merozoites eventually differentiate into
gamonts, which undergo sexual reproduction and regenerate oocysts that are excreted in
feces (Garcia, 2002).

Clinical Disease and Treatment

Cryptosporidiosis is usually self-limiting in immunocompetent adults. Symptoms
may include nausea,

fever,

abdominal

cramps,

anorexia

and diarrhea.

In

immunocompromised hosts, however, this disease may be chronic and life threatening.
This is due to the impaired immune system especially in AIDS patients who have CD4
cell counts less than 180-cells/mm3 (Garcia, 2002). Four clinical categories of AIDSrelated cryptosporidiosis have been identified: a cholera-like illness requiring
rehydration therapy, chronic diarrheal illness, intermittent diarrheal illness and transient
diarrheal illness (Garcia, 2002).

Other organs

have

been

involved

13
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in

cryptosporidiosis and include the lungs, ears, pancreas, stomach and the biliary tract,
which is the most common site of extraintestinal infection.
Cryptosporidium is resistant to antimicrobial drugs and there is no cure to date.
The establishment of the host cell vacuole may protect Cryptosporidium from
antimicrobial agents. Treatment options are not indicated in immunocompetent hosts. In
immunocompromised hosts, treatment involves partial restoration of immune function.
Cases have shown that the use of highly active anti-retroviral therapy (HAART) may
restore CD4 cell counts and resolve diarrhea (Clark, 1999). Bovine hyperimmune
colostrum has also shown some promise in these patients (Garcia, 2002). Antibiotics
have been used such as paromomycin and azithromycin with some partial efficacy of
treatment. Nitazoxanide has recently been tested in Mexico and cured nearly 100% of
patients with Cryptosporidium (Garcia, 2002). Controlled clinical trials with this drug
are currently under way in the United States.

Epidemiology and Prevention.
Cryptosporidium has been isolated in chickens, cattle, turkeys, mice, rats, guinea
pigs, horses, dogs, cats, sheep, pigs, rhesus monkeys and humans (Bowman, 1999).
Zoonotic transmission is one means of exposure to humans. Two major genotypes within
Cryptosporidium parvum have been identified. Genotype 1 is exclusive for humans and
genotype 2 has a broad host range. Different species show marked host specificity and
evidence exists to consider C parvum genotypes 1 and 2 as different species. Hundreds
of fecal samples from humans were analyzed in a study performed by McLauchlin et al
(2000). Genotype 1 was recovered in 38% of the samples and genotype 2 in 62%. Fecal
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samples from livestock animals were also analyzed and yielded genotype 2 only.
Animals serve as potential reservoirs for humans.
Transmission occurs through the fecal-oral route. Nosocomial infections, day
care center outbreaks and waterborne outbreaks have been documented. Cases of
Cryptosporidium parvum are reportable to the State Department of Public Health
regardless of the age of the patient. Cumulative cases in the United States in 2002
totaled 3,512 (MMWR, 2003). Because oocysts are fully infective when passed in feces,
person- to-person transmission occurs when stool material is contacted. Direct contact
may occur through sexual practices and indirect contact may occur by exposure to
contaminated water supplies. Since the oocyst is only 4-5 um in diameter, filtration of
public water supplies may not be sufficient for removal. The oocysts have a
demonstrated resistance to chlorination (Guerrant, 2001).
The dose required for infection, the infectious dose (ID) has been proven to be
as low as 30 oocysts (Garcia, 2002). Surveys indicate prevalence rates of
cryptosporidiosis in Europe and North America to be between 25% to 35% (MMWR,
2003). For the disease to be sustained in a community, susceptible and infected hosts
must exist along with oocysts in the environment for the life cycle to propagate.
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Giardia Lamblia
Life Cycle
The life cycle of Giardia lamblia begins with the ingestion of the cyst form,
which reaches the small bowel, and, in response to the low pH, excysts into the motile,
feeding trophozoite form. Using flagella and the ventral disk, the trophozoite moves
from the small intestine to the duodenum and jejunum where it attaches to the intestinal
epithelium. Trophozoites do not appear to penetrate the epithelium and may remain
attached to the mucosal surface until it sloughs off the tip of the villus approximately
every 72 hours (Garcia, 2002). The trophozoites are pear-shaped and have a concave
ventral disk, which they use for attachment. They have four pairs of flagella, two nuclei,
two axonemes, and two median bodies and are 10 to 20 um long and 5 to 15 um wide.
Trophozoites encyst as they move down through the colon. During encystation,
flagella are retracted, the cytoplasm becomes condensed and the cyst wall is secreted.
This process of encystation is a key step in the life cycle of Giardia that allows the
organism to survive between hosts outside the human body. The cysts can survive for
three months in water at 4°C (Olson et al., 1999). They are usually oval-shaped; contain
four nuclei, axonemes and median bodies. They measure 11 to 14 um in length and 7 to
10 um wide.

Clinical Disease and Treatment.
The cyst form is infectious and an inoculum of 10 to 100 cysts is required to
infect humans (Garcia, 2002). The incubation time to infection ranges from 12 to 20
days before the acute stage begins, which lasts only a few days. The organisms are
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present in the duodenal mucosa, but do not cause pathology, as they do not penetrate the
mucosa. Symptoms of the acute phase can include nausea, anorexia, fever, chills and a
sudden onset of explosive, foul-smelling diarrhea. Stools may have increased amounts
of fecal fat and mucus, but no blood is present. Fat absorption may be disrupted due to
the presence of trophozoites coating the mucosal lining. Rapid multiplication of
trophozoites by binary fission creates a barrier between the intestinal epithelial cells and
the lumen causing interference with nutrient absorption (Garcia, 2002).
A chronic phase may follow the acute phase and induces symptoms of brief,
recurrent diarrhea followed by normal stools or even constipation. Antigenic variation is
a factor in the development of this chronic stage as certain surface antigens may allow the
organism to survive better in the intestinal tract. Some other patients are asymptomatic
and continue to pass cysts in stools.
Giardiasis occurs often in patients with hypogammaglobulinemia, but has not
become the problem it was expected to in AIDS patients. AIDS patients do not appear to
be more susceptible to Giardia than do healthy people and when cases occur; treatment is
available and effective for this protozoan (Garcia, 2002).
In summary, giardiasis causes infection ranging from an asymptomatic carrier
state to severe malabsorption syndrome. Factors contributing to the variation in the
effects of exposure include the strain of Giardia, dose, age of the host and immune
system function of the host.
Once an infection is diagnosed, treatment is recommended for all cases of Giardia
for several reasons. First, the infection may cause subclinical malabsorption. The
symptoms may be periodic and if a carrier state develops, asymptomatic carriers are
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potential sources of infection for others with whom they may come in contact. The
treatment of choice is metronidazole for all cases except during pregnancy. Other drugs
are available and have been used successfully including paromomycin and tinidazole.
Epidemiology and Prevention.
Transmission of viable cyst forms can occur through many modes including the
ingestion of contaminated food or water, direct contact with an infected individual such
as children in day care centers, any group of people living in close quarters or through
oral/anal sexual practices, especially in male homosexuals. Areas with poor sanitation,
such as those that travelers and/or campers may encounter, have resulted in giardiasis
being referred to as "traveler's diarrhea". There are also occupations that increase the
likelihood of exposure, including sewage and irrigation workers and clinical laboratory
workers handling fecal samples. Waterborne outbreaks have occurred in the United States
and have been associated with hikers and campers drinking stream water that was
contaminated with fecal material from animal reservoirs, such as beavers.
Increased susceptibility has been demonstrated in patients with decreased gastric
acidity and also with malnutrition in young children in developing countries. The disease
is more prevalent in children than adults and is now reportable to the State Public Health
Department and the Centers for Disease Control only in those patients five years old and
younger in the United States. The total number of cases reported in 2002 in the United
States was 16,124 (MMWR, 2003). Epidemics among adults in this country are seen in
association with fecally contaminated food or water. Dogs, cats and other animals can
also carry Giardia infection.
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To prevent transmission of this disease, personal hygiene must be addressed in all
patient populations. Improved sanitation measures can be effective in controlling the
person-to-person spread of infection. Travelers are advised to avoid drinking from local
water supplies when traveling to foreign countries and to limit intake to bottle water.
Iodine disinfection of drinking water as well as the use of filtration systems may serve to
allow the decontamination of water sources for campers and travelers.
Recovery Methods
Current P art 503 Methods for Ascaris Recovery
Monitoring for Ascaris VHO under the Part 503 Rule (EPA, 1996) requires the
use of magnesium sulfate flotation to recover the ova in biosolids samples (Appendix).
One liter of liquid sample or 450 grams of solid sample is blended with a surfactant and
allowed to settle overnight. The supemate is removed and a second blending and settling
step is performed to remove debris and purify the sample. The Ascaris ova are finally
concentrated from the sample by the use of magnesium sulfate to create a density
gradient, which will float the ova out of the sample matrix for removal. Samples are
analyzed for the presence of Ascaris ova using a Sedgwick-Rafter counting chamber and
light microscopy. If ova are recovered, the sample must be incubated for three to four
weeks at room temperature to allow for viability testing of the recovered ova. Ova are
analyzed microscopically after this incubation period for the presence of active, motile
larvae internally which are interpreted as viable if present.
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Recovery of Protozoa
Little research has been done on the occurrence and recovery of
Cryptosporidium and Giardia in sewage when compared to similar research concerned
with water. There are significant differences between water and sewage including
numbers of parasites, which suggests that techniques currently used for water may not
be suitable for sewage samples. Method 1623 is currently being used to test water for
Cryptosporidium and Giardia (Appendix G). This approved EPA method uses filtration,
immunomagnetic separation (IMS) and fluorescent antibody (FA) testing to recover and
identify these protozoans in water samples. Robertson et al (1992) clearly demonstrated
that large volume filtration is less efficient than grab sampling for detecting these two
protozoans in sewage effluent.
Bean and Brabants (2001) have adapted the Part 503 protocol for Ascaris
recovery to successfully recover both Cryptosporidium parvum oocysts and Giardia
lamblia cysts (Bean, 2001). The protocol uses a combination of flotation and
centrifugation techniques to concentrate the protozoa. Once the concentration procedure
is complete, organisms are recovered using immunomagnetic separation (IMS) and
identified by using fluorescent antibody staining (DFA). Bean et al (1999) applied the
Dynal® immunomagnetic separation technique (IMS) to concentrate oocysts of
Cryptosporidium and cysts of Giardia from biosolids successfully (Appendix).
Antibody-coated beads specific for Giardia and Cryptosporidium bind to antigens on the
cyst and oocyst walls and because these beads are magnetized, they can be isolated
easily from the sample matrix resulting in a clean suspension of oocysts once they are
dissociated

from

the

bead

particles. Merifluor® direct fluorescent antibody
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staining (Appendix) is then performed on the IMS concentration product to identify the
protozoa and confirm their identity using fluorescently labeled antibodies which are
specific for the oocyst and/or cyst cell wall antigen target. The IMS sample is incubated
with the fluorescein isothiocyanate-conj ugated monoclonal antibodies directed against
the antigenic components of Cryptosporidium oocysts and Giardia cysts. The stained
preparation is examined under a fluorescent microscope for the simultaneous detection
and enumeration of Cryptosporidium oocysts and Giardia cysts.
Viability Assays
In addition to optimizing recovery rates, another goal of this project is to assess
methods of viability testing for both Cryptosporidium parvum and Giardia lamblia. It is
mandatory to test for organism viability when helminth ova or protozoan cysts are
recovered to measure risk of exposure. If all organisms recovered are non-viable, then
treatment has been effective and the organisms do not pose a public health risk. The
viability of Ascaris ova is determined using an incubation and light microscopy to
visually identify viable larval forms (EPA, 1996). For the two protozoa in this study,
viability was measured using the benchmark of animal infectivity, which is thought to
be the most sensitive method for determining infectivity of oocysts. Hence, the animal
infectivity assay was used to evaluate the performance of other assays. Because animal
infectivity is costly, labor intensive and slow to provide results, other methods to
determine protozoan viability were evaluated.
The first comparison evaluated infectivity in neonatal mice and detection of the
p-tubulin messenger RNA (mRNA) for Cryptosporidium parvum. The mRNA
technique is based on the principle that mRNA in oocysts, as in all cells, is
21

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

subject to rapid post-mortem decay (Widmer, 1999). The presence of a selected mRNA
transcript, as detected by reverse-transcription PCR (RT PCR) can therefore be used as
a marker of viability. Viability of Cryptosporidium parvum was also assessed using
excystation of oocysts and vital staining with DAPI/PI (Widmer, 1999).
For Giardia lamblia, infectivity in mongolian gerbils and vital dye staining was
compared. The cysts were stained with fluorescein diacetate and propidium iodide
(FDA/PI) and then examined with a fluorescent microscope. FDA-positive cysts
fluoresce intensely green and represent viable cysts. Pi-positive cysts fluoresce bright
orange and represent nonviable cysts.
Bench Scale Treatment Processes
The fates of these parasites in bench scale Class A and Class B treatment
processes were assessed in the final phase of the project. A composting model using a
biosolids extract was used to assess heat inactivation of these parasites in Class A
treatment process. A bench scale model of Class B lime stabilization processing was also
set up to test for inactivation of the pathogens. There are currently no data available for
the fates of either Cryptosporidium or Giardia in Class B sludge treatment processes such
as lime stabilization. Better data on the fate of these organisms during treatment
processes will assist in determining the relative risks of exposure to parasites associated
with land application of biosolids. Class A biosolids processes have been shown to
inactivate representative model pathogens and therefore require no parasite testing. It is
assumed that the combination of using a documented process in conjunction with a
bacterial limit to document process performance will result in the inactivation of all
parasites. Documentation of how biosolids treatment methods affect these parasites
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will be beneficial in assessing the public health risk associated with land application of
biosolids. If a process can inactivate protozoa and helminthes, the resulting biosolids may
be beneficially used in a timely manner.
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CHAPTER TWO
RECOVERY OF PARASITES

INTRODUCTION

EPA Requirements for Parasite Evaluation in Biosolids
The U.S. Environmental Protection Agency (EPA) revised its guidelines in
October 1999 for the detection of Ascaris ova as an indicator of parasites in water,
wastewater, sludge and composted biosolids {Environmental Regulations and
Technology: Control of Pathogens in Vector Attraction in Sewage Sludge). The intention
of the revised guidelines is to increase sample volume, providing for a more
representative sample for analysis and increasing the likelihood that parasitic ovum will
be detected if they are present. Ascaris was chosen as the indicator organism based on
the knowledge that the ova are capable of surviving in the environment for long periods
of time and are resistant to environmental effects (Yanko, 1988). There are currently no
requirements for analyzing biosolids for the presence of protozoa. When Ascaris was
chosen as the indicator organism, protozoa such as Cryptosporidium parvum were not yet
recognized as human pathogens.

Recovery of Ascaris Ova
The most significant change to the original protocol is the substantial increase in
the volume of sample tested- from 50 g to 300 g of dry or thick sample, and from 450 mL
to 1L or more of liquid sample (estimated to contain at least 50 g of dry solids). Other
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protocol changes include the additional steps of soaking thick samples overnight,
blending and settling to ensure liquefaction. The revised protocol utilizes 7X limbro
detergent in place of Tween 80 as a surfactant, and includes an additional process of
coating glassware with organosilane. Both protocols utilize density gradient
centrifugation to create a layer of ova; however, the revised protocol makes use of
magnesium sulfate to accomplish this, whereas the previous protocol utilized zinc sulfate
solution. The revised protocol employs a 400-mesh sieve to capture the Ascaris ova,
which are subsequently quantified using a Sedgwick-Rafter counting chamber.
Recovery efficiency, processing time, final volume of sample generated for
microscopic analysis, and the amount of materials and reagents required to complete the
analysis vary depending on the type of sample and the percentage of total solids. For
example, a highly liquid sample with a low percentage of total solids (<5%) produces a
smaller packed pellet for processing and subsequent examination, thereby requiring fewer
materials and reagents and less processing time. In addition, such a sample will generate
a relatively "clean" product for microscopic analysis, minimizing solids and debris that
could interfere with counting Ascaris ova. However, a sample with a high percentage of
total solids (>50%), as is found with composted biosolids, requires additional processing
time because the sample may be difficult to pass the through the initial screening. Also,
high total solids samples must be separated into smaller aliquots for centrifugation.
Processing times for samples containing 5% to 50% total solids vary depending
on overall sample consistency. If the volume of packed sediment exceeds five milliliters,
which will occur in a solid sample, the sediment must be redistributed evenly among
additional tubes and centrifugation must be repeated, which tends to result in a larger
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number of tubes and increases processing time. Using the revised protocol, processing
time for hands-on sample manipulation is between 85-100 minutes. The entire turn
around time from start of sample processing to the final sample read is three days. These
times are slightly longer than what was required for the previous protocol: 60-70 minutes
of direct sample processing and a turn-around time of two days. Using the revised
protocol, the final report can be ready in 3 days if no Ascaris ova are present in the initial
reading; however, the sample must be incubated for 3 to 4 weeks to assess viability if ova
are present. This additional incubation increases reporting time to a minimum of 3 weeks.
Seeding and recovery experiments were conducted using three samples varying in
percentage total solids and type of treatment. The samples included untreated wastewater,
lime-stabilized biosolids and composted biosolids. Using the revised protocol guidelines,
which now require 300 grams or 1 liter of sample, recovery results were compared with
those obtained using the previously required 50 gram or 450 ml sample sizes.
In the seeding study, ova recovery data differed significantly depending on
sample type. Solid samples were processed prior to seeding and evaluated for the
presence of viable helminth ova and larvae. Recovery rates were obtained by seeding
1450 ml of untreated wastewater (0.44%TS), 350 g of lime-stabilized biosolids
(66.6%TS), and 350 g of composted biosolids (50.3%TS) with 3500 Ascaris ova.
Original ova counts were performed in triplicate using a haemocytometer. Following
stirring, two aliquots were removed from each material sample, 300 g or 1000 ml and 50
g or 450 ml, depending on the material. All aliquots were processed using the revised
protocol and final results reported as the total number of Ascaris ova, unembryonated
Ascaris ova, and first-, second-, or third-stage larvae per gram dry weight (GDW).
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Recovery data for the three sample types and volumes is presented in Table 1.
The recovery rate of Ascaris ova and larvae from untreated wastewater seeded with ova
was 12.02% using a 1-L sample with the revised protocol. When analyzing the 450-ml
sample aliquot, the recovery rate was only 2.75%. For lime-stabilized biosolids, the
recovery rate was 4.38% using a 300-gram aliquot and 7.99% when processing the 50gram aliquot. The recovery rate for the composted biosolids was 4.5% for the 300-gram
aliquot and 9.61% for the 50-gram aliquot.

Table 1

Sample
Type

Amount processed

1 Liter
450 ml
300 grams
Limed
50 grams
300 grams
Compost
50 grams
*GDW: Gram Dry Weight

Raw

Ascaris Recovery Efficiency
% Total
Final
# Ova per
Volume
*GDW
Solids
10 ml
7.25
0.04%
10 ml
1.66
9.4 ml
0.658
66.60%
10 ml
1.2
1.5 ml
0.895
50.30%
8 ml
1.91

# larva per
*GDW
2.75
2.22
0.14
0
0.318
17.17

% Recovery
12.02%
2.75%
4.38%
7.99%
4.50%
9.61%

‘Larva per GDW is not included in the calculation for % Recovery

Table 1: Ascaris recovery efficiency in raw, lime stabilized and composted biosolids
Ascaris ova were spiked into three types ofbiosolids; raw sludge, limed and composted
biosolids, with varying %total solids ranging from 0.04% (raw) to 66.60% (limed) to
evaluate recovery of ova using different volumes of sample. The sample volumes
included those previously required in the VHO protocol (EPA) and the new requirements
of sample volume based on the revised protocol.
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Composted biosolids samples at 50 and 300 g and lime-stabilized biosolids at 300
g required dilution to minimize interferences when analyzing the sample for the presence
of Ascaris ova. Total solids in these samples were greater than 50%. A 1:2 dilution was
performed for the 50-g composted biosolids sample and a 1:4 dilution was performed for
the 300 g composted and lime-stabilized biosolids samples.
Recovery rates were low and may be explained by several factors, including
variation in total solids percentage, sample type, and sample volume. Due to the high
percent total solids in the composted and the lime-stabilized biosolids, these samples
were manipulated a great deal. The large amount of solid material may have acted to
bind to the ova and the larval forms. These data show that the percent recovery for the
1L sample was higher using the revised protocol than that for the 450 mL sample only in
the untreated wastewater category, which may be attributed to the sample having lower
percent solids and, therefore, requiring less manipulation and having fewer particles to
adsorb ova and larvae. The high percent recovery rate for the 1 L untreated wastewater
sample may have been due to the fact that the sample contained only 0.44% TS.
Recoveries were lower in the composted and lime-stabilized biosolids samples, which
contained more than 50% total solids. The use of lime in the treatment process may
degrade parasites, which could influence the loss of organisms. Low recoveries in all
samples may also be attributed to inadequate spatial distribution of Ascaris ova within the
samples.
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Percent recovery also varied among the volumes of sample spiked. For
example, recovery was 12.02% for the 1-L untreated wastewater sample, but only 2.75%.
for the 450-mL sample. Ova were spiked into 1450-ml untreated wastewater (2.41 ova
per milliliter) before the sample was split into 1-L and 450-mL aliquots, which contained
2410 and 1084.5 ova, respectively. Percent recovery for the 50-g sample was roughly
twice that of the 300-g sample for both lime-stabilized and composted biosolids.

Analysis of Loss of Ova

The next steps in analysis of Ascaris recovery were to determine where loss of
ova was occurring in the revised EPA protocol. Initial recovery experiments were
performed

Ascaris lumbricoides ova seeded at 5 ova/mL into 1Liter of RO water

using the revised EPA protocol. The goals of these initial experiments were to evaluate
ova recovery in an RO water matrix to determine loss due to sample processing and
eliminate the biosolids matrix as a variable in recovery efficiency.
VHO recovery includes an initial step where samples are processed by blending
with buffered water containing a surfactant, 7X Limbro. The blended sample is poured
through a screen to remove large particles and allowed to settle overnight. The
supernatant fluid is decanted and the sediment subjected to density gradient
centrifugation using magnesium sulfate (specific gravity 1.20). The flotation procedure
concentrates parasite ova in a surface layer and removes them from sample debris. A
smaller mesh screen is used to remove particulates and the concentrate is incubated at
room temperature (28°C) for three to four weeks until Ascaris control ova are fully
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embryonated. One mL samples are evaluated microscopically using a light microscope
with phase contrast and lOx and 40x objectives. Ova are enumerated on a SedgwickRafter counting chamber and classified as either embryonated or unembryonated based
on microscopic examination.
Five thousand Ascaris lumbricoid.es ova were seeded into 1 liter of RO water.
Seeded ova were enumerated in triplicate 1 mL aliquots using a Sedgwiek-Rafter
counting chamber. 10 mL of the 1 Liter spiked sample volume was screened in 1 mL
aliquots to ensure the presence of 5 ova per mL and allow for statistical accuracy. The
sample was processed using the revised EPA protocol. This protocol was reviewed and
steps representing significant sample manipulation were chosen for taking samples (Chart
1). These samples represent select steps in the process including blending, aspirating and
settling of the sample prior to flotation. At each step in the process, 10 mL of sample was
removed and evaluated for the presence of Ascaris ova by evaluating all 10 mL in 1 mL
aliquots using a Sedgwick -Rafter counting chamber. In addition to taking aliquots at
each step, materials that would have normally been discarded were retained and
evaluated for the presence of ova in an effort to determine the loss at each major step.
This included retaining sediments and aspirates and screening for the presence of ova
using a Sedgwick-rafter counting chamber to enumerate the detected ova.
A 25% loss was calculated based on the first five samples collected in the
protocol. Sources for loss include washing the sample through a 50-mesh sieve and two
aspiration steps in the protocol as indicated in Chart 1. Prior to flotation 75.5% of the
ova were recovered. Following flotation the final recovery was 9.1% indicating that the
most significant loss occurred during the MgSC>4 flotation step. To further elucidate the
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source of the loss the sediment was examined and was found to contain 29.5% of the ova
seeded. The 400-mesh sieve was also directly seeded with 100 ova and subsequently
washed. It was determined that the use of the 400-mesh did not result in significant loss
of the ova by pouring ova through the mesh sieve and recovering 100% of them. A
hydrometer was used to routinely measure the specific gravity when preparing the
MgS04. The hydrometer was calibrated to ensure accuracy prior to performing seeding
studies. Although vessels were coated with sigmacoat, a silicone solution in heptane that
forms a thin film on the glass surface and repels water, it is speculated that the loss not
accounted for may be a result of vessel transfer.
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Chart 1
Seeded 4905 ova into 1500ml
Sample 1: 39 ova in 10 mL = 5850 Ova in 1500 mL*
Blend Liquid

I
Settle Overnight with 7X Limbro

I
Aspirate (#1: 0 ova seen)& Blend again with RO water
Sample 2: 26 ova in 10-mL= 5200 ova in 2-Liters 88.9% recovery 11.1% loss
Settle 2 Hours

1
Aspirate (#2: 0 ova seen)& Mix on stirrer with 7X Limbro
Sample 3: 30 ova in 10-mL=5400 ova in 1800-mL 92.3% (88.9%) recovery

1
Strain through 50-mesh sieve (Sieve wash: 22 ova = .38% loss

I
Settle 2 hours with 7X Limbro

4
Aspirate (Aspirate #3: 9 ova seen = .15%) and mix sediment
Sample 4: 119 ova in 10-mL=4760 ova in 400-mL 81.4% recovery 6.97% loss
Put in 50-ml tubes. Centrifuge & Aspirate supernate
(Aspirate #4: 3 ova seen = .05%)

I
Sample 5:138 ova per mL=4416 ova in 32-mL 75.5% recovery 5.85% loss
Add M gS04 & Vortex. Centrifuge

MeSQ4 Sediment: 1728 - 29.5% loss

A
Pour supernate through 400-mesh sieve (MgS04 rinse: 2 ova = .03%)
Rinse 400-mesh sieve to collect Ascaris

I
Centrifuge and Aspirate supernate (Aspirate #5: 0 ova seen)

I
Resuspend pellet in 7-mL acid alcohol

4
Centrifuge, Aspirate Supernate (Aspirate #6: 6 ova seen = .1% loss)
resuspend pellet in 4-mL 0.1 NH2 S 0 4

4
FINAL READ - 531 ova in 5-mL 9.1% recovery 36.77% loss

Chart 1: Flow Chart to diagram recovery of Ascaris ova (Formalin Fixed) from RO
W ater to assess loss in procedure These subsamples represent blending, aspirating and
settling of the sample throughout the protocol prior to flotation. Each 10-mL subsample
was removed and evaluated for the presence of Ascaris ova by examining all 10-mL in 1mL aliquots using a Sedgwick -Rafter counting chamber.
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In the second recovery experiment, 450 mL of a raw liquid sample representing
<5% total solids was spiked with 2250 Ascaris ova.' 10 mL of the spiked sample volume
was screened in 1-mL aliquots to ensure the presence of 5 ova per mL and allow for
statistical analysis. Processing of the sample using the current EPA accepted protocol for
the recovery of viable helminth ova resulted in a 59.29% recovery. Further processing
using a modified ethyl acetate sedimentation protocol resulted in recovery of 44.8% of
the ova recovered by flotation. The modified ethyl acetate sedimentation procedure is
currently used in clinical diagnostic laboratories to process human fecal samples for the
recovery of ova and parasites (Garcia, 2001). Sedimentation methods of concentration
may lead to recovery of all protozoa, oocysts, ova and larvae in samples, but the
concentrate contains more debris than the product of a flotation procedure. Based on this
experiment sedimentation of the flotation product from a liquid matrix does not appear to
improve recovery.

35

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 2
Sample Type

% Recovery by Flotation

Liquid

59.29%

% Recovery by
Sedimentation of Flotation
44.80%

Semi-Solid

2.67%

87.09%

Compost

0.78%

9.52%

Table 2: Flotation and Sedimentation of Ova
Recovery of Ascaris lumbricoides ova seeded at 5 ova/mL into 50g or 450-mL sample
using current EPA accepted protocol for recovery of viable helminth ova.
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During the next phase of recovery experiments, 50 grams of a semi-solid and
compost sample, representing 10% and 50% total solids respectively, were spiked with 5
ova/ml following an initial soaking and blending step. 10 mL of the spiked sample
volume was screened in 1-mL aliquots to ensure the presence of 5 ova per mL and allow
for statistical analysis. Processing of the semi-solid and compost samples, using the
current EPA accepted protocol for the recovery of viable helminth ova, resulted in a
2.67% and 0.78% recovery respectively. Further processing of the flotation product using
a modified ethyl acetate sedimentation protocol resulted in an 87.09% recovery for the
semi-solid sample and a 9.52% recovery for the compost sample (Table 2). Based on this
experiment (n=3) sedimentation of the flotation product from a solid matrix does appear
to improve recovery.
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Table 3

| Recovery vfAscaiis ova in 1000 riiLROwater

,

. .

Pull Number
1
2
3
4

% Recovery
100
88.9
88.9
81.4

% Loss
0
11.1
0
7.5

Sources of Loss

5
FINAL
READ

75.5
9.1

5.9
66.4

.05 Aspirate 4
29.5 MgS04 Sediment
.03 MgS04 Rinse
0 Aspirate 5
.1 Aspirate 6

0 Aspirate 1
0 Aspirate 2
.38 Sieve Wash
.15 Aspirate 3

Table 3: Recovery of Ascaris ova in RO water
The magnesium sulfate flotation protocol w as asse ssed for step where loss of
ova occurs. After the settling, aspirating and sieving steps, 24.5% of the ova
were lost. Of the 75.5% recovered after these initial steps, only 9.1% were
recovered in the final sample after magnesium sulfate flotation.
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Recovery of Protozoa:

Cryptosporidium varvum and Giardia lamblia Recovery Experiments
There are no current recommended or validated methods for recovering protozoa
from biosolids. Adapting the current EPA White House protocol for Ascaris ova for the
detection of protozoa, specifically Cryptosporidium parvum and Giardia lamblia, would
allow the evaluation of biosolids samples for protozoa along with helminthes. The
strategy put forth in these experiments is based on size differential between Ascaris ova
and protozoan oocysts/cysts. At each washing and settling step in the ova procedure,
where the ova are settled out or retained on the 400 mesh sieve, the oocysts would remain
in the discarded wash solution (aspirate) or in the rinse water that passed through the 400
mesh sieve. The following experiments were conducted to determine if oocysts could be
recovered from the aspirate or sieve rinse water using the immunomagnetic separation
(IMS) procedure and immunofluorescent detection (DFA).
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Table 4

Giardia . .
Dynal Recovery
Efficiency
Merifluor Direct IFA
Efficiency
Seed 1
Seed 2
Seed 3
Seed 4
Seed 5
Seed 6
Seed 7 Centrifugation

38.40%'

27.80%

99%

99%

3.20%
3.90%
8.00%
3.70%
3.70%
6.70%

4.80%
12%
3.30%
2.40%
3.90%
12%

41.70%

Table 4: Recovery of Protozoa in RO Water
Recovery of Cryptosporidium parvum and Giardia lamblia cysts and oocysts seeded at 3
oocysts and 3 cysts per mL into 1-Liter of RO water using current Whitehouse document
protocol for recovery of Viable Helminth Ova.
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Three thousand Cryptosporidium parvum oocysts and Giardia lamblia cysts were
seeded into 1-Liter of RO water. Cysts and oocysts seeded were enumerated by flow
cytometry prior to seeding. Cysts and oocysts were seeded at each of 7 steps within the
current Whitehouse document protocol (October 1999), representing significant sample
manipulation. These steps represent blending, aspirating and settling of the sample
throughout the protocol prior to flotation (Chart 2). Each step was evaluated
independently with a separate one-liter sample seeded with 3000 cysts and oocysts and
the sample was processed to completion. For example, at seed number seven, 3000 cysts
and oocysts were added to 1-Liter of RO water and the sample was centrifuged at 3000
rpm for 10 minutes. Following centrifugation, the supemate was decanted and the pellet
was resuspended in 10-mL RO water. The sample was then processed using Dynal®
Immunomagnetic Separation (IMS) (Appendix C) with subsequent visualization using
Merifluor® Direct Immunofluorescence (DFA) (Appendix D).
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Chart 2
(SEED 1) Seeded 3000 cysts & oocysts into 1000-mL
Biend Liquid

4
Settle Overnight with 7X Limbro

1
Aspirate & (SEED 2) Blend again with RO
(SEED 3) Settle 2 Hours
4
Aspirate & Mix on stirrer with 7X Limbro
4
(SEED 4) Strain through 50-mesh sieve
4
Settle 2 hours with 7X Limbro
4
Aspirate and mix sediment (SEED 5)
Put in 50-ml tubes. Centrifuge & Aspirate supernate (SEED 6)

4
Add MgS0 4 & Vortex. Centrifuge (SEED 7)

4
Pour supernate through 400-mesh sieve & collect wash through sieve

4
Centrifuge sieve wash, resuspend in 10-mL RO water

4
(SEED 8) Perform Dynal® IMS and Merifluor® DFA

RO W a t e r
The chart outlines the seeding experiments (seeds 1-8) for protozoa. At each
seeding point, 1-8, cysts/oocysts were seeded and the process was completed from
that point on for recovery.

C hart 2: R e c o v e r y o f P r o t o z o a ( F o r m a lin F ix e d ) f r o m
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Recovery calculations for seeds 1-7 are based on the efficiency obtained for
Dynal® Immunomagnetic Separation (IMS) and Merifluor® Direct immunofluorescence
Assay (DFA), as all samples were concentrated and visualized using these techniques.
IMS recovery efficiency is reported by the manufacturer to be 60%-95% in water, and
there have been no reports on the use of IMS to recover Cryptosporidium or Giardia in
biosolids. Recoveries using IMS in these experiments were 38.4% for Cryptosporidium
oocysts and 27.8% for Giardia cysts. There doesn’t appear to be a significant variation
in recoveries for steps 1-6. The discrepancy in these recovery rates may be a result of
using a different enumeration technique for the seeded oocysts and cysts versus the
recovered oocysts and cysts.

Discussion
Flotation protocols take advantage of the relative low density of protozoan cysts and
helminth ova to achieve a partial purification of those organisms using a single
sedimentation or centrifugation step. A flotation method could be used as an initial step
to enrich for C. parvum oocysts in complex suspensions, such as sludge matrices. This
method would not be used as a stand-alone procedure; it would be combined with other
methods, probably immunomagnetic separation, to improve the detection of oocysts and
cysts in sludge.
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CHAPTER THREE
A SURVEY OF WASTEWATER SOLIDS TO ASSESS THE
PREVALENCE OF Cryptosporidium, Giardia and Ascaris lumbricoides

INTRODUCTION
The ubiquitous occurrence of Ascaris, Cryptosporidium and Giardia
species in biosolids samples from different regions of the United States was assessed over
a 15-month period.

Thirty-eight biosolids samples were analyzed from 11 states

including the Northeast, Northwest, Southwest and Central regions of the United States
(Chart 1). Types of treatment that produce sludge were raw (untreated) sludge, Class B
lime stabilized and composted biosolids with % total solids ranging from 3.26 %(raw) to
80.84% (compost). The mean percent total solids of all samples included in this study
were 36.04%. The objective of the prevalence assessment was to determine whether the
three parasites were present in biosolids using current methods for recovery. Viability of
recovered parasites was not assessed and presence/absence only was determined.
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Table 1

State

Number of samples Ascaris

Giardia

Cryptosporidium

Washington

1

0

0

1

Wyoming

2

0

0

1

Indiana

1

0

0

0

Pennsylvania

5

2

0

0

New York

4

0

1

1

Vermont

4

0

1

0

Maine

3

0

1

Massachusetts

2

0

0

0

Maryland

2

1

1

1

Texas

7

2

1

2

Arizona

7

1

1

0

-

3

Table 1: Regional Sampling and Prevalence of Parasites in Biosolids Samples
States included in the 38-sample study cover the Northeast, Northwest, Southwest and
Central United States

Methodology
Organisms were concentrated by magnesium sulfate flotation following the EPA
Part 503 approved methodology for recovery of Ascaris lumbricoides ova (EPA Part 503
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Biosolids Rule 1994) and by the ethyl acetate sedimentation technique (Garcia, 2001).
The volume of sample used in these experiments was 50-g solid or 450 ml liquid sample.
The sample was blended and allowed to settle overnight before the supernatant
was removed. Magnesium sulfate was added to bring the sample volume to 50 ml and
the sample was centrifuged. The supernatant fluid was examined for the presence of ova,
cysts and/or oocysts.
Ethyl acetate sedimentation was also performed on these samples to compare
sedimentation with flotation for parasite concentration. The sample was washed two
times by mixing with phosphate buffered saline and centrifuging before the ethyl acetate
was added. The sample was then mixed and centrifuged and the resulting sediment was
examined for ova, cysts and/or oocysts. Protozoa were purified from 5-ml samples of
flotation or sedimentation product using Dynal® immunomagnetic separation (IMS).
Purified protozoa (20 ul of the IMS product) were identified using Merifluor direct
immunofluorescence (DFA).
Results
Overall prevalence of each parasite is the sum of positive samples obtained by
recovery method, flotation, or sedimentation. The protozoans are at least as prevalent as
Ascaris in these study samples as shown in Table 2.
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Table 2

Organism
Ascaris

Percent Samples Positive
15.8%

Cryptosporidium

23.7%

Giardia

15.8%

Table 2: Prevalence of Parasites in U.S. Samples
Thirty-eight samples including untreated, lime stabilized and composted biosolids from
the United States including the Northeast, Northwest, Southwest and Central regions

Cryptosporidium oocysts were recovered from 9 of the samples tested (23.7%)
and were the most prevalent of the three parasites in this study (Table 2). Only one
sample evaluated contained both Cryptosporidium and Ascaris ova (2.63%). Giardia
cysts were recovered from 6 samples (15.8%). None of the samples evaluated contained
both Giardia cysts and Ascaris ova.
Comparison of percent recovery by the two different methods is summarized in
Table 3. Ethyl acetate sedimentation is more effective at concentrating protozoa based on
the findings of this study. The flotation procedure is more effective for recovery of large
helminth ova like Ascaris.
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T a b le 3
Ethyl Acetate Sedimentation

Zinc Sulfate Flotation

7.7%

0%

12.8%

2.6%

7.7%

2.6%

7.7%

10.5%

Protozoa Recovery:

Giardia cysts
Cryptosporidium oocysts
Both
Ascaris Recovery

Table 3: Comparison of percent recoveries
Two concentration methods; ethyl acetate sedimentation and zinc sulfate flotation, were
used to evaluate recovery of protozoa

Data analysis
Crosstabulations were performed using SPPS statistics software to evaluate the
strength of association between the presence of Ascaris ova and Cryptosporidium oocysts
(Table 4), and Ascaris ova and Giardia cysts (Table 5). One sample contained both
Cryptosporidium and Ascaris. The Pearson chi square was 0.194 and the p value=0.660.
There appears to be no association between the presence of Ascaris and Cryptosporidiwn
in this set of data. No samples contained both Giardia and Ascaris. The Pearson chi
square was 1.336 and the p value=0.248.. There appears to be no association between the
presence of Ascaris and Giardia in this set of data.

48

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

T a b le 4

Crosstab
Count

Presence/ Absence
of Ascaris

Presence/Absence of
Cry pto
Positive
Negative
1
5

Positive

Negative

Total

8
9

Total
6

24

32

29

38

Table 4: Crosstabulation of Presence/Absence of Ascaris and Cryptosporidium in
Biosolids Samples One sample contained both organisms and a total of 6 were positive
for Ascaris ova and a total of 9 were positive for Cryptosporidium oocysts
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Table 5

Crosstab
Count
Presence/Absence of
Giardia
Positive
Negative
Presence/ Absence
of Ascaris

Positive
Negative

6
6

Total

Total
6
26
32

Table 5: Crosstabulation of Presence/Absence of Ascaris and Giardia in Biosolids
Samples No samples contained both organisms. A total of 6 were positive for Ascaris
ova and a total of 6 were positive for Giardia cysts
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6
32
38

Discussion
Monitoring biosolids samples for the presence of protozoa is not currently
required, even though organisms such as Cryptosporidium parvum and Giardia lamblia
have been identified as pathogens of concern in wastewater solids. The survival of
Giardia poses a significant risk associated with the land application of biosolids. More
than 900 cysts per gram-wet weight were discovered in anaerobically digested biosolids
(NRC, 2002). When the EPA Part 503 Rule was written, C. parvum was considered a
veterinary pathogen and had not been associated with human disease.

Giardia and

Cryptosporidium must be considered potential public health risks, especially since their
small size may allow the cysts/oocysts to move more easily through soils into
groundwater as compared to the larger helminth ova.
The prevalence data presented here demonstrate that Ascaris is not a reliable
indicator of the presence of either Cryptosporidium or Giardia species. The absence of
Ascaris ova from biosolids samples does not indicate that protozoa are also absent from
the sample. The prevalence assessment was performed using recovery methods that have
been shown in this research to be inefficient. Although these parasites cannot be reliably
recovered, the prevalence assessment demonstrated that these parasites do exist in
biosolids.
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CHAPTER FOUR
EVALULATION O F F E C A L COLIFORMS, SALMONELLA ,
CRYPTOSPORIDIUM PARVUM, GIARDIA LAMBLIA AND
ASCARIS LUMBRICOIDES P E R S IS T E N C E U N D E R L IM E
S T A B IL IZ A T IO N C O N D IT IO N S

INTRODUCTION
Biosolids are categorized as Class A or Class B. Class A biosolids
contain pathogens below detectable levels whereas Class B sludge
contains pathogens which are reduced in number. The requirements for
use and disposal of biosolids will depend on the classification. The use of
lime to reduce or eliminate pathogen content in sewage sludge represents a
simple and inexpensive method of treatment by which Class B sludge can
be generated (Farrell 1974). Lime stabilization is a process where calcium
hydroxide (Ca(OH)2 ) or calcium oxide (CaO) is added and the pH
elevated to 12 for 2 hours and then reduced to 11.5 for 22 hours. Lime has
been in use for a number of years for the disinfection and odor suppression
of solid wastes.

Fecal coliform bacteria are used to indicate the potential presence
of pathogens in class B biosolids (Ryan 1994). Bacteria are important
pathogens with regard to biosolids and land application because the
potential

exists ' for regrowth

following treatment (Yanko,
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198

The density of fecal coliforms in sewage are estimated to be 103/ml (Yanko,
2000). The EPA Part 503 regulations require that fecal coliform density may not
exceed one thousand most probable number (MPN) or colony forming units
(CFU) per gram of total solids (dry weight basis) if the sludge is to qualify as
Class A sludge, or must be less than two million MPN or CFU per gram total
solids (EPA 1999) if the sludge is to qualify as Class B sludge. Salmonella is a
microorganism that is of concern in biosolids. Yanko (1988) found that
Salmonella was frequently found in biosolids in a survey of biosolids in the
United States. The EPA Part 503 regulations require that treated sewage sludge
must be monitored for fecal coliforms or Salmonella species and have a
Salmonella density of less than three most probable number (MPN) per four
grams total solids (dry weight basis) to qualify as a Class A sludge (EPA 2000).

Protozoan parasites include Giardia and Cryptosporidium, which cause
acute gastrointestinal distress resulting in severe diarrhea and may lead to death in
immunocompromised individuals (Garcia 1997). Cryptosporidium parvum is
commonly found in surface water, is highly resistant to conventional methods of
water treatment, and therefore may be a better candidate for the monitoring of
human parasites in biosolids for treatment effectiveness.

Helminth ova are currently utilized to indicate effective treatment of
biosolids for land application. (Yanko 1988) (WHO 1986). Current EPA 503
regulations require biosolids to be screened for A. lumbricoides; however, there
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are little data available to indicate the effects of lime stabilization on the viability
of these pathogens.

Materials and Methods
Lime Treatments
Lime treatments were performed independently in 50-mL volumes of Ca
(OH)2 solution

for

inactivation

of bacteria,

protozoa

and

helminth.

Cryptosporidium parvum and Giardia lamblia were inoculated to achieve a final
concentration of 106 oocysts (+/-5.1%) and 5 x 105 cysts (+/-3.9%) per ml,
respectively. Aliquots of 3,000 Ascaris lumbricoides ova were resuspended in the
matrix for both the control and the test samples. Samples were continually mixed
on a stir plate and the initial pH and temperature were recorded for control and
test beakers. The pH of the test beakers was simultaneously adjusted to 12.0 using
an 8% aqueous slurry comprised of calcium hydroxide and deionized water.
Approximately 0.4 - 0.5 mL of calcium hydroxide slurry was required to elevate
the pH to 12.0, corresponding to a lime dose of approximately 80 g/kg total
solids. The pH was maintained at 12.0 for 2 hours at which time, 0.1 N HC1 was
added drop by drop until a pH value of 11.5 was achieved and maintained for the
duration of the experiment. Experiments were performed at room temperature
with temperature and pH readings recorded hourly for control and test beakers.
The viability of bacteria was evaluated at time points 0.1, 2, 12 and 24 hours. The
infectivity of protozoan pathogens was evaluated at 0.1, 2, 12, 24, 48, and 72
hours. Survival of helminth ova was evaluated at 24, 48 and 72 hours. Following
54
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lime stabilization, test beakers were neutralized with 0.1 N HC1 and aliquots were
removed from designated control and test beakers for enumeration.

Bacteria
Fecal Coliforms
Fecal coliform densities in RO water samples obtained following lime
stabilization experiments were evaluated using a most probable number assay
(MPN) according to method 1680, established by the EPA for fecal coliform
detection in biosolids by multiple tube fermentation (EPA, 1998). The MPN assay
is an estimation of bacterial density and employs culture specific media combined
with elevated temperature to isolate and enumerate fecal coliforms. A
presumptive step using lauryl tryptose broth (LTB) (Difco) as the selective
enrichment medium and a completed step using E. coli (EC) (Difco) media permit
the recovery and isolation of fecal coliforms. Ten-fold serial dilutions were
created and inoculated into 5 test tubes containing sterile LTB and a Durham
fermentation tube to indicate gas production. Tubes were incubated for 48 hours
at 35°C and observed at both 24 and 48 hours for the presence of presumptive
growth indicated by gas or acid production in the fermentation tubes. Failure to
produce gas or acid in the LTB media within 48 hours was recorded as a negative
presumptive test. LTB presumptive positive tubes were transferred to
fermentation tubes containing sterile EC media. EC fermentation tubes were
incubated in a water bath at 44.5°C for 24 hours. Gas production in EC broth in 24
hours was considered a positive fecal coliform reaction. Failure to produce gas
was a negative reaction and indicated fecal coliform bacteria were not present.
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Results of the MPN procedure were reported in terms of MPN/g total solids
calculated from the number of positive EC culture tubes. Positive control cultures
consisting of E. coli were included in each assay to ensure negative results were
not from inhibition.

Salmonella sp.
Salmonella densities following lime stabilization experiments were
evaluated using a most probable number assay (MPN) according to method 1682
established by the EPA for Salmonella detection in biosolids by multiple tube
fermentation (EPA 1998). Sample dilutions were created using phosphate
buffered saline. Enrichment was accomplished using selenite brilliant green sulfa
(SBG) broth followed by isolation on xylose-lysine deoxycholate agar (XLD).
Positive samples were confirmed with triple sugar iron agar (TSI), lysine iron
agar (LIA), and urease broth followed by positive serological typing using
polyvalent antisera. Results of the MPN procedure were reported in terms of
MPN/g total solids. Positive control cultures consisting of Salmonella
typhimurium and negative control cultures consisting of E. coli were included in
each assay to ensure negative results were not from inhibition.

Protozoa
Cryptosporidium parvum

C. parvum oocysts, Moredun (MD) isolate (Okhuysen, 2002); propagated
in immunosuppressed mice (Yang et al 1996) were used throughout this study.

56

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Fecal pellets were collected from infected animals and homogenized in 10 ml of
water. Oocysts were purified by sedimenting on a step gradient of 15%-25%
(w/v) Nycodenz (N, N ’-bis (2,3 dihydroxypropyl acetamido-2, 4,6-tri-iodoisophthalamide) (Sigma; St. Louis, Missouri) in water (Widmer et al 1998),
brought to 50 ml in water, and pelleted by centrifugation at 4000 x g for 15 min.
Purified oocysts were resuspended in 1 ml of water. Following lime stabilization,
oocysts were neutralized to pH 7 with 0.1 N HC1, transferred to 50 ml conical
polypropylene centrifuge tubes, and precipitated by centrifugation at 4000 x g for
15 min. Pellets were resuspended in 2 mL of RO water and the oocyst
concentration determined with a hemocytometer in duplicate. In some
experiments, the presence of Ca(OH)2 crystals interfered with obtaining accurate
oocyst counts, making it necessary to immunofluorescently label the oocysts
(Merifluor Cryptosporidium/Giardia, Meridian Bioscience Inc., Cincinnati,
Ohio). Oocysts were then counted by epifluorescent microscopy.

Animal Infectivity
Neonatal CD-I mice 1-3 days of age (Charles River Laboratories,
Wilmington, Mass.) were orally infected with oocysts suspended in 5-pl water
using a pipette (Tzipori, 1998). Infected and uninfected control mice were
sacrificed on day 7 post-infection, the intestine removed and homogenized in 300pl phosphate buffered saline in a microcentrifuge tube. A portion of 10 pi of
intestinal slurry from each mouse was spread in each well of 10-well Teflon
coated microscope slides and the samples air-dried. Oocysts were stained by
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immunofluorescence and detected by epifluorescence microscopy. Samples with
a minimum of 1 immunofluorescently labeled oocyst were scored as positive.
Positive control mice were infected with oocysts from the same stock as used for
the treatments. Oocysts for the negative controls were heat-inactivated at 70°C for
20 min (Fayer, 1994).

Giardia lamblia

Giardia lamblia cysts of strain H3 purified from experimentally infected
gerbils were obtained from Waterborne, Inc., New Orleans, Louisiana. Cysts were
purified on sucrose and Percoll density gradients and shipped in PBS
supplemented with penicillin, streptomycin (500 U/ml each) and gentamycin
(50g/ml).

To assess the infectivity of the cysts, Mongolian gerbils (4-wk-old,
Charles River, Wilmington, Massachusetts) were each orally infected with a 20 pi
suspension of 1000 cysts (first experiment) or 500 cysts (second experiment)
(Widmer et al, 2002). Groups of 8 animals were used for each treatment. Fecal
pellets were collected from the gerbils on day 6, 8, 10, 12, and 14 post-infection.
The presence of G.

lamblia cysts in the feces was monitored by

immunofluorescence using the Merifluor Cryptosporidium!Giardia kit (Meridian
Diagnostics, Cincinnati, Ohio) as described (Widmer et al, 2002). Fecal samples
were scored as positive if a minimum of 1 immunolabelled cyst was detected.
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Helminth
Ascaris lumbricoides
A.

lumbricoides ova were purchased from Tropical Biologicals

(Guaynabo, Puerto Rico). Viable ova were concentrated from fecal samples
collected from infected humans in the Dominican Republic and shipped in a
suspension of 2% formaldehyde to inhibit microbial growth. The suspension was
stored at 20°-23°C and aerated daily by removing the lid to exchange the air
inside, replacing the lid and shaking four-five times. Storage of ova for more than
two weeks required decanting the supernatant and replacing with fresh 2%
formaldehyde every two or three weeks. Viability of ova was assessed prior to use
in experiments following the EPA Part 503 method. Lime treatment and
neutralization was performed as described for C. parvum. The entire test and
control volumes were centrifuged at 1000-x g for 10 minutes. The supernatant
fluid was decanted and the pellet resuspended in 10 mL of RO water. 1 ml sample
aliquots were screened using Sedgwick-Rafter counting chambers under lOx
magnification. Viability was determined by observing motile larvae in
embryonated ova by microscopic evaluation under 40x magnification. One
hundred ova were evaluated for each time point.
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Data Analysis
Statistical analysis of lime stabilization trials to evaluate treatment
effectiveness for bacteria was conducted using a general linear model within the
SPSS statistical software package. Percent viability was calculated for helminth
ova test and control samples and the difference was used to determine overall
treatment effectiveness.

Infectious dose values for C. parvum were calculated

according to Reed and Muench (1938) and using the logit method of Finch et al.
(1993) and are shown in Figure 2.

Results
Bacteria
The results of three trials conducted with fecal coliforms (E. coli) and
Salmonella sp. spiked into a limed water matrix at room temperature are
presented in Figure 1. In two trials, following 0.1 hours of liming E, coli
concentrations were below detectable levels (<1 MPN/ gram total solids). In one
trial, the concentration of fecal coliforms following initial liming (0.1 hours) was
6.0 x 105 MPN/g total solids and was below detectable levels following 2 hours of
liming at pH 12. This data point was considered an outlier and was not included in
statistical analysis. In all trials, Salmonella sp. concentrations were below
detectable levels (<3 MPN/4 grams total solids).

60

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Cryptosporidium parvum
The average reduction (n=3) in oocyst concentration was 74.2% (±18.8%)
for the controls and 81.7% (±29.9%) for the treatments (2 hr and 24 hr treatments
pooled). Oocyst concentrations in control and treated samples dropped
significantly during the experiment. The reduction in oocyst concentration was
not related to the treatment, since the difference between mock treatment and the
actual treatment was statistically not significant (p=0.75, paired /-test), nor was it
related to the duration of the exposure (2 hr vs. 24 hr, p=0.41, /-test). The reason
for the loss in oocysts was not investigated, but is likely to have resulted from the
adherence of oocysts to glass and plastic surfaces and incomplete recovery during
centrifugation.

Single-dose experiments

To assess the effect of liming on C. parvum oocysts, single-dose
experiments were performed with oocysts exposed to lime solution for 0-72
hours. Immunofluorescent analysis of the 7-day post-infection mouse intestinal
homogenates demonstrated that the treatments did not inactivate the oocysts. All
samples, including those treated for 72 hours, contained infectious oocysts.

Dose-response experiments

The infectivity of oocysts treated with lime for 2 hr and 24 hr was
compared with that of mock-treated control oocysts using dose-response
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experiments. Groups of

8

neonatal mice were infected with

6

oocyst doses

ranging from IQ2 to 104. The infection was assessed 7 days post-infection as
previously described. A positive control group was infected with 5000 oocysts per
mouse pup and a negative control group received the same number of heatinactivated oocysts. The cumulative method and the logit method (Finch, 1993)
both showed that lime stabilization for 24 hr did not inactivate the oocysts (Figure
2). To the contrary, the treatment increased the infectivity of the oocysts by more
than 4-fold. Whereas the calculated ID50 for the untreated oocysts was 1180, the
ED50 for the treated oocysts was only 263 oocysts. The same effect was observed
after a 2-hr exposure; the ID50 for the control oocysts was 986 and for the treated
sample was 128 oocysts, a more than 7-fold reduction in ID50 .

Giardia lamblia
Single-dose experiments in gerbils were performed to assess the
inactivation of G. lamblia cysts exposed to lime solution for 0 hr, 24 hr, 48 hr and
72 hr. In the first liming experiment, cysts were suspended in water. A second
experiment was performed using sludge. In contrast to C. parvum, cysts limed
were completely inactivated during a 48 hr or 72 hr treatment. Following a 24-hr
exposure, infectious cysts were still detected, as demonstrated by the presence on
day 10 post-infection of 2 positive animals in a group of 8. None of the eight
animals infected with cysts exposed to lime for 48 hr and 72 hr excreted cysts
between day 6 and day 14 post-infection, consistent with complete inactivation.
All positive control animals inoculated with untreated cysts became infected,
whereas 2 animals infected with heat-inactivated cysts (negative control)
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remained negative until day 14 post-infection, when the experiment was
terminated. Mock treatments, during which cysts were subjected to the same
conditions as the treated cysts, except that no lime was added to the cyst
suspension, slightly reduced cyst infectivity at 24 hr, 48 hr and 72 hr as compared
to the positive control group. The proportion of positive gerbils in these mock
control groups was 8/8, 7/8, 5/8 and 7/8 for 0 hr, 24 hr, 48 hr, and 72 hr mock
treatment, respectively.

In a second experiment liming was performed in sludge instead of water.
This experiment confirmed the inactivating effect of lime. Lime treatments for 24
hr, 48 hr, and 72 hr resulted in a complete cyst inactivation; whereas the 0-hr
treated and all the mock treated treatment groups infected all animals (8/8).

Ascarts lumbricoides
The results of two trials conducted with Ascaris lumbricoides ova spiked
into a limed water matrix at room temperature are presented in Figure 3. In both
trials A. lumbricoides ova in test samples remained viable following 72 hours of
liming at room temperature. There was no significant difference between viability
of control and test samples at all time points (p value= 0.52).

Discussion
Very few data are currently available indicating the persistence of
pathogens under lime stabilization conditions. The goal of this study was to
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evaluate the persistence of fecal coliforms, Salmonella sp., protozoa and helminth
under lime stabilization conditions. Organisms were evaluated in an RO water
matrix, due to problems with recovery efficiency from solid matrices (Bean and
Brabants 2001). The water matrix represents a best-case scenario since it has been
documented that organic material and particulate matter enhance the survivability
of microorganisms (Kato et a i, 2001 and Straub et al., 1993).

The results indicate that lime stabilization effectively inactivated fecal
coliforms and Salmonella in a water matrix at room temperature (28°C) when 8%
calcium hydroxide slurry created with RO water was added to achieve a pH of 12.

Fecal coliforms are currently used as the microbiological parameter
evaluated for Class B certification. Therefore, fecal coliforms are the only
parameter used to assess treatment effectiveness. These experiments demonstrate
that fecal coliforms cannot be used as an indicator of treatment effectiveness for
all pathogens. Fecal coliforms were inactivated immediately upon addition of
lime in an RO water matrix at room temperature. The data demonstrate that lime
stabilization is effective for inactivation of fecal coliform bacteria when evaluated
in limed water.

Indicator organisms for Class A certification include Salmonella.
Salmonella was evaluated and results revealed similar inactivation to fecal
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coliforms, thus indicating that bacterial organisms in these experiments behave
similarly and are effectively inactivated when exposed to lime in a water matrix.

Ascaris lumbricoides is the current parasite indicator for treatment
effectiveness to obtain Class A certification although this organism is not
consistently present in biosolids samples due to varying geographic distribution
(Bean and Brabants, 2001) and inefficient recovery methods (Bean and Brabants,
2000). Previous work performed in our laboratory and in this study indicate that
while Ascaris is resistant to liming, its scarcity in sludge and low recovery
efficiencies prevent it from being a good indicator organism. For these reasons,
protozoa, which are ubiquitous in the environment and recovered as frequently as
A. lumbricoides, were included in this investigation. The results demonstrate
viability of A. lumbricoides ova following 72 hours of liming. In comparison, C.
parvum and G. lamblia, evaluated under the same conditions, demonstrated
enhanced infectivity as a result of exposure to lime.

Conclusions
These results demonstrate that liming is effective for reduction of bacteria
when evaluated in an RO water matrix at room temperature. The results also
demonstrate the ineffectiveness of liming to inactivate Ascaris lumbricoides and
Cryptosporidium parvum, which is of particular concern with regard to land
application of biosolids. The results warrant further investigation to determine if
inactivation of the organisms evaluated is similar in a solid matrix where they
may be less susceptible to alkaline inactivation. This research presents data in
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what should be an on-going investigation to evaluate methods of sludge or
biosolids preparation in an effort to minimize public health threats associated with
land application of biosolids, maximize potential benefits of biosolids and move
our society towards sustainability.
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Figure 1: Fecal Coliforms and Salmonella sp. Inactivation in Three
Trials Conducted in Limed RO W ater at Room Temperature
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Figure 2
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Figure 2: Dose-Response Curves for Cryptosporidium parvum
Dose-response curves were obtained for the inactivation of C. parvum
with lime using the cumulative method of Reed and Muench (1938) (left)
and the logit method of Finch et al. (1993) (right). The 50% cumulative
infection and 0 logit used for determining the ID50 values are shown with
dashed horizontal lines. Note the increase in oocyst infectivity (lower
E D 5 0 ) in response to the treatment.
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Figure 3: Ascaris lumbricoides Inactivation in Two Trials Conducted
in Limed RO W ater at Room Temperature (28°C)
A. lumbricoides ova seeded remained viable following 72 hours of lime
stabilization at 28°C.
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CHAPTER FIVE
EVALUATION OF CRYPTOSPORIDIUM PARVUM, GIARDIA LAMBLIA
AND ASCARIS LUMBRICOIDES SURVIVAL UNDER HEAT
INACTIVATION CONDITIONS

INTRODUCTION
Composting is a process that converts organic wastes into a soil amendment
product. Organic wastes are partially decomposed in the process by bacteria, worms, and
other living organisms resulting in a product, which can be used as fertilizer or a soil
conditioner. Composted materials are used to provide nutrients to the soil and replenish
depleted organic matter lost through farming. During the composting process, biosolids
are stabilized, odors are reduced and high temperature is thought to kill pathogens
(Corbitt, 1990).

The inactivation of Cryptosporidium parvum, Giardia lamblia and

Ascaris lumbricoides was evaluated under temperature conditions of 55°C and 70°C in
this study. All composting high temperature inactivation experiments were performed
using a biosolids extract in order to maintain consistency and use the same sample matrix
for all experiments. This composting protocol was kindly provided by Bill Yanko and
Shawn Thompson of the Los Angeles County Sanitation District, Los Angeles, Ca.
Thermal death times were achieved for all parasites using heat inactivation at 70°C. No
animal infectivity was performed on protozoa since viability assays demonstrated that
cysts and oocysts were non-viable by the end of the 60-minute experiments.
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The organic components of sewage sludge are biologically decomposed during
composting and the resulting product is drier and more stable than dewatered, raw or
digested sewage sludge. Pathogens should be below detectable levels as a result of
heating during the composting process (Krogmann, 2001).

In aerated static pile

composting, a bulking agent such as wood chips is added to dewatered biosolids and
piled onto a concrete composting pad. The mixture is mechanically aerated during a 26day period to oxygenate the pile and support aerobic biological activity and to reduce the
heat and moisture content of the compost pile mixture. After this 26-day period, the
mixture is cured or dried. The resulting product is screened to remove wood chips before
the compost moves to distribution.
During composting, bacteria are responsible for 80-90% of the biological
degradation of the organic matter found in sewage sludge (Krogmann, 2001).
Actinomycetes and fungi are also involved in biological degradation. Bacteria survive up
to temperatures of 75°C and have reduced degradation rates at higher temperatures.
Factors that influence microbial degradation during composting include moisture content,
oxygen content, temperature, carbon/nitrogen ratio and pH. The optimum pH range for
composting is between 7 and 8 (WEF, 1995).
Because most microbial decomposition occurs in liquid films on the surface of
particles, moisture is essential to the decomposition process. The minimum moisture
content ranges between 12% and 25% and varies depending on the coarseness of the
feedstock and the composting technology used (Krogmann, 2001). Oxygen supply is
essential and aeration serves to dry the compost as well as control temperature. The
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optimum temperature during the high-rate decomposition is 55°C. At temperatures over
60°C, the diversity of microorganisms is reduced and at 75-80°C no biological activity
was detected (Strom, 1985).

Temperature requirements to reduce pathogens below

detectable levels are 3 days above 55°C in aerated static pile composting systems.
Biodegradable wastes usually contain enough macronutrients including carbon to sustain
the composting process with the exception of nitrogen. Carbon/nitrogen ratios (C/N)
should be between 20:1 and 30:1 when composting begins and varying the composition
of the initial feedstock can control this.

Materials and Methods
All composting high temperature inactivation experiments were performed using
a biosolids extract in order to maintain consistency and use the same sample matrix for
all experiments. Bill Yanko and Shawn Thompson of the Los Angeles County Sanitation
District kindly provided this protocol.

Biosolids Extract
Four hundred grams of an aerobically digested sludge was suspended in 1 liter of
RO water and centrifuged (30 minutes at 10,000 x g) to remove the solids fraction. The
supernatant fluid was filtered through a series of membrane filters of decreasing pore size
to 0.45 m l. The extract was then heated to 70°C for 30 minutes to inactivate any
organisms penetrating the filter and refrigerated for use in future experiments.
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Inactivation Experiments
Nine hundred ul aliquots of biosolids extract was dispensed into microfuge tubes
(one per time point) and heated to temperature (55°C or 70°C) by floating in the water
bath for 30 minutes prior to inoculation. Microorganisms were added to each tube to
achieve a final concentration of 103 Giardia lamblia cysts, 103 Cryptosporidium parvum
oocysts, and 90-100 Ascaris lumbricoides ova per tube. Inoculated tubes were gently
mixed and then floated in the heated water bath. At selected time intervals, one tube was
removed from the water bath, cooled and analyzed for viability. For the 55°C composting
experiments, viability assays performed for Cryptosporidium parvum included
excystation only. Viability for C. parvum from composting experiments performed at
70°C included both excystation and vital staining (DAPI/PI). Protocols for both of these
viability assays are included as appendices. Light microscopy was performed to identify
broken, intact and/or empty cysts of Giardia lamblia as an initial screening of viability.
Vital staining (FDA/PI) was then performed only on those samples that contained intact
cysts. Viability of Ascaris lumbricoides was determined by microscopic evaluation of
ova. Untreated oocysts/cysts/ova were used as a positive control and negative controls
included the extract alone, which contained no organisms, and heat inactivated
oocysts/cysts (65° for 30 minutes).

Results
55°C Inactivation Experiments
Two experiments were run at 55°C to assess the inactivation of helminth ova and
protozoan cysts/oocysts.

In the first experiment, Ascaris lumbricoides ova and
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Cryptosporidium parvum oocysts were tested over a 60-minute period, which included
samples taken at 9 time points, beginning 5 minutes after the sample was heated at 55° C
and ending after one hour at this temperature (Table 1). The second experiment was
performed at the same temperature and with the same biosolids extract, but time points
were limited to 15,30,45 and 60 minutes.

Table 1

Time point
(minutes)
5

% Viability
Ascaris ova

% Viability
Cryptosporidium
oocysts

Run 1
87

Run 1
83

Run 2

Run 2

% Intact
Giardia
cysts
(Run 2 only)

% Viability
Giardia cysts

(Run 2 only)

100

88
10
75

80

70

68

98

76

68

90

80

55

76

68

42

70

59

15
64

70

73

72

20
25
60

75

65

30
71

56

40
71
45
45
50

82

60

89

28
73

Table 1: Heat inactivation of Ascaris lumbricoides ova, Cryptosporidium
parvum oocysts and Giardia lamblia cysts at 55°C in Biosolids Extract
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Helminth ova
The first experiment, trial 1, to assess inactivation or loss of viability over 60
minutes of time in biosolids extract at 55°C showed that Ascaris viability was not reduced
at this temperature.

The ova were subject to this temperature and one sample was

removed from the water bath and incubated at room temperature for 30 days before being
evaluated for viability microscopically. A second run with fewer time point pulls also
showed that after 60 minutes at 55°C, 73% of the ova were viable (Figure 1). The ova
controls performed prior to starting these experiments were 88% viable (trial 1) and 75%
viable (trial 2).
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Figure 1: Inactivation of Ascaris lumbricoides ova at 55 degrees Celsius
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Cryptosporidium parvum oocysts
Both trials 1 and 2 demonstrate that viability (assessed by excystation) is reduced
after 60 minutes. In trials 1 and 2,78% and 75% of the oocysts were viable respectively
at the start of the experiment (viability assessed by excystation). When comparing the
loss of viability after 60 minutes, trial 1 demonstrated that viability dropped from 78% to
28% and trial 2 demonstrated that viability dropped from 75% to 42% (Figure 2).

Figure 2

Minutes

Figure 2: Inactivation of Cryptosporidium parvum at 55 degrees Celsius
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Giardia lamblia cysts
Giardia lamblia cysts were assessed first by light microscopy to determine
intactness before performing additional viability testing. If all cysts appeared damaged
by light microscopy, no additional viability testing was performed. If intact cysts were
present, as was seen in the four test time points (15,30,45 and 60 minutes), vital staining
using FDA/PI followed microscopy and 100 cysts were counted. When comparing the
loss of viability after 60 minutes, viability dropped from 89% at the start of the trial
(untreated control) to 59% after 60 minutes at 55°C (Figure 3).

Figure 3
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Figure 3: Inactivation of Giardia lamblia at 55 degrees Celsius
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70°C Inactivation Experiments
Three experiments were conducted at 70°C to assess the inactivation of A.
lumbricoides ova, C. parvum oocysts and G. lamblia cysts. Four time-points were
sampled for each parasite over a 60-minute period (Table 2).

Vital staining and

excystation were performed on C. parvum oocysts. G. lamblia cysts were initially
screened by light microscopy to determine intactness. If intact cysts were identified, vital
staining was then performed on G. lamblia. Ascaris ova viability was assessed by
microscopy.

Table 2
Time
Point

(minutes)

%Viability
Ascaris
N=3

% C. parvum
Excystation
N=3

% C. parvum
"viable
DAPI/PI
N=3

% G. lamblia
intact
N=3

% G. lamblia
viable
FDA/PI
N=3

15

83

9

0

7

6

30

72

0

0

0

0

45

22

0

0

0

0

60

0

0

0

0

0

Table 2: Average Percent Heat inactivation of Ascaris lumbricoides ova,
Cryptosporidium parvum oocysts and Giardia lamblia cysts at 70°C in Biosolids
Extract
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Helminth ova
Three separate trials were performed and the mean of the three runs is shown in
Table 2. Ova were subjected to 70°C and one sample was taken from the water bath at
each time point and incubated at room temperature for 30 days before being evaluated
microscopically for viability. After 60 minutes at 70°C, no viable helminth ova were
found (Figure 4).
Figure 4
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Figure 4: Inactivation of Ascaris lumbricoides ova at 70 degrees Celsius
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Cryptosporidium parvum oocysts
After 15 minutes at 70°C, 9% of the oocysts were viable when assessed by
excystation (Figure 5) and no viable oocysts were seen with the use of vital staining. At
all time points thereafter, either excystation or vital staining demonstrated no viable
oocysts.
Figure 5
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Figure 5: Inactivation of Cryptosporidium parvum oocysts at 70 degrees Celsius
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Giardia lamblia cysts
After 15 minutes at 70°C, 7% of 100 cysts appeared intact and 6% stained as
viable using FDA/PI. At all time points thereafter, no viable cysts were demonstrated by
vital staining (Figures 6 and 7).

Figure 6
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Figure 6: Inactivation of Giardia lamblia cysts at 70 degrees Celsius assessed
by Microscopy
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Figure 7
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Figure 7: Inactivation of Giardia lamblia at 70 degrees Celsius
assessed by Vital Staining
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Discussion
Pathogens are destroyed during composting due to thermal killing, antibiotic
action or by the decomposing organisms and their products (Golueke et al., 1958). This
study was designed to determine whether pathogens could survive thermophilic
temperatures present during composting.

Thermal death times were achieved for all

parasites using heat inactivation at 70°C. Comparative data on the effects of thermal
treatment on ova and oocysts of parasites indicate that the infectivity is reduced by
thermal treatment (Moce-Llinina et al., 2002). When sewage sludge is composted to
achieve 70°C for a minimum of one hour, helminth ova, protozoan cysts and oocysts
should be destroyed although when organisms associate with particulates in a complex
sample matrix like biosolids; some protection from heat may be afforded. Once the
oocysts, cysts and helminth ova are destroyed however, there is no threat of regrowth
with parasites as has been demonstrated with bacteria.

No animal infectivity was performed on protozoa since viability assays
demonstrated that cysts and oocysts were non-viable by the end of the 60-minute
experiments. Process controls for composting to include monitoring the temperature of
piles can ensure that pathogens are inactivated. Composting as a method of treating
biosolids is effective in controlling odors, which makes acceptance of land application
more tolerable for the general public. One disadvantage of composting is the threat of
bioaerosol creation. It is difficult to control this potential health threat, especially to
workers in the composting facility and neighboring communities. The major areas of
concern in bioaerosol creation are fungi; specifically Aspergillus fumigatus, and
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endotoxins and risk assessment has not been conducted for bioaerosols in composted
biosolids (Milner et al., 1994).

Class A treatment methodologies result in a “virtually” pathogen free product.
These methodologies typically achieve a high temperature as part of the process as
compared to Class B processes, which do not. A Class A product will have a reduction in
pathogens, which is greater than the reduction achieved in Class B products. For this
reason, there are a growing number of sewage treatment plants moving to Class A
processes in order to produce a product which the public will be more likely to accept as
safe.
There are many factors including the production of heat that contribute to the
breakdown of organic material during the process of composting.

To test biosolids

samples for the possible presence of any potential pathogen is impossible due to the
limitations of methods of detection and the cost of testing. There are emerging pathogens
of concern for which no methods of detection even exist. Therefore, process controls may
be a more effective way of ensuring that the biosolids product meets certain pre
determined standards before being labeled a “Class A” product. If controls can ensure
that the process successfully achieved the Class A product by meeting time, temperature,
pH, etc., this could be a measure of quality assurance for the production of Class A
biosolids by composting.
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I. Procedural Section:
A. Scope & Applicability: This test method describes the detection, identification,
enumeration and determination of viability of Ascaris ova in water, wastewater,
sludge and compost. These pathogenic intestinal helminths occur in domestic
animals and humans. The environment may become contaminated through direct
deposition of human or animal feces or through sewage and wastewater
discharges to receiving waters. Ingestion of water containing infective Ascaris
ova may cause disease.
B. Summary of Method: This method is used to concentrate pathogenic Ascaris
ova from wastewater, sludge, and compost Samples are processed by blending
with buffered water containing a surfactant. The blend is screened to remove large
particulates. The solids in the screened portion are allowed to settle out and the
supemate is decanted. The sediment is subjected to density gradient centrifugation
using magnesium sulfate (sp. 1.20). This flotation procedure yields a layer likely
to contain Ascaris and some other parasitic ova if present in the sample. Small
particulates are removed by a second screening on a small mesh size screen (38p).
Proteinaceous material is removed using an acid-alcohol/ethyl acetate extraction
step. The resulting concentrate is incubated at 26 EC until control Ascaris eggs
are fully embryonated. The concentrate is then microscopically examined for the
categories of Ascaris ova on a Sedgwick-Rafter counting chamber.
C. Definitions:
1. Helminth Ova: Literally translates into Aworms eggs 6. Includes
Nematodes (roundworms), Cestodes (tapeworms), and Trematodes
(flukes). This procedure includes three Nematodes: Ascaris, Trichuris, and
Toxocara, and one Cestode: Hymenolepis.
2. Class A Biosolids: contain an ova density of <1 viable ova/ 4g of total
solids on a dry weight basis.
3. Ascaris lumbricoides: A large roundworm having very thick transparent
shelled eggs covered by a mammillated albuminoid outer layer. (55-75 um
long X 35-50 um wide)
4. Trichuris trichiura: A whip-worm which has a thick shelled, barrel
shaped egg that is yellow-brown with prominent, clear, mucoid plugs at
the ends. (50-55 um long X 22-24 um wide)
5. Toxocara canis and cati: Small roundworm which has brownish eggs
almost spherical with surficial pits, and are unembryonated when laid. (7585 um long X 60-75 um wide). * Important because humans are often
accidental hosts which result in visceral larval migrans.*
6 . Hymenolepis nana and diminuta: Are the smallest of the tapeworms.
H.nana has a spherical to subspherical egg with a thin shell with two
thickenings at opposite poles. (30-47 um X 20-60 um). H.diminuta is
larger with a thick shelled yellow-brown egg (70-85 um long X 60-80 um
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wide). * Important because it is the most common tapeworm in the United
States.*
D. Safety Warnings:
l.The Analyst must know and observe normal safety procedures and
proper handling should be followed closely when working with
wastewater. Mouth-pipetting is prohibited.
E. Cautions: Field and laboratory staff collecting and analyzing environmental
samples are under some risk of exposure to pathogenic microorganisms. Staff
should apply safety procedures used for pathogens to handle all samples.
F. Inferences:
1. Sludge samples should not be frozen during transport or storage since
freezing could be detrimental to the viability of ova present in the samples.
Sludge samples should be stored at refrigerator temperature.
2. Numerous transfers of the sample to new vessels may decrease the
recovery of ova.
3. Under microscopic examination, interfering debris such as: pollen,
starch, plant hairs, and vegetable material may interfere with reading of
the sample (Figure 1).
G. Personnel Qualifications:
1. Laboratory Analyst/Technician: should have a B.S. and/or at least 1
year training in working with wastewater. Technicians should be well
versed in safety as well as proper handling of wastewater samples both
semisolid and fluid. The analyst must also demonstrate acceptable
performance during an on-site evaluation.

H. Apparatus & Materials:
1. Centrifuge, Table Top, that can sustain forces of at least 660 x g with a
swinging bucket rotor to hold 15, 50,100 and 250 ml centrifuge glass or
plastic conical bottles.
2. Centrifuge tubes 250 ml, 100 ml
3. 15 ml and 50 ml Teflon tubes
4. Analytical balance capable to 10 mg.
5. Thermometers 0EC to 50EC , checked against a NIST thermometer
6 . Automatic Pipette, with filter
7. Blender and Blender Jar
8 . Incubator capable of maintaining temp. 26EC
9. Laboratory vacuum source and vacuum apparatus (2 L flask or larger)
stopper to fit vacuum flask, fitted with a glass or metal tubing as a
connector for 1/4 inch tygon tubing.
10. Binocular light microscope with 10X, 40X, 100X objectives
11. Gloves
93

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

12.2L Pyrex Beakers
13. 48 and 400 Mesh Tyler Stainless Steel Sieve
14. Autoclave
15. Large Plastic Funnel
16. Wooden applicator sticks
17. Pasteur Pipettes and bulb
18. Hydrometer
19. Slides and Cover slips
20. Sedgwick-Rafter cell
21. Teflon Spatula
22. Large test tube rack to accommodate 100 or 250 ml centrifuge tubes
23. Small test tube rack to accommodate 15 ml and 50 ml centrifuge tubes
24. Number A0" stoppers
25. Wash bottles (500 ml) label AWater. 0
26. Spray bottles 2 (16 fl oz.) label one AWater,0 and one A7X Limbro"
I. Reagents
1. Dulbecco=s Phosphate Buffered Water (Sigma # D5652)
2. 7X Limbro (Sigma #)
3. Magnesium Sulfate sp. gr. 1.20 (Fisher # Z68-500)
Check sp.gr with hydrometer: to low add powder to high add water.
4. Acid/Alcohol Solution: V/V
0.1 N Sulfuric Acid H2 SO4 (Fisher # A300-500)
35% Ethyl alcohol (Fisher # A407-500)
5. 0.1 M Sulfuric Acid (Fisher # A300-500)
6 . Fresh Ascaris ova for positive control purified from Ascaris infected
human fecal material purchased from Tropical Biologicals Puerto Rico
J. Instrumentation and Methods of Calibration:
1. Incubator at 26EC, Thermometer in the bath checked against NIST
thermometer.
2. Analytical Balance, NIST Weights (1,10,100 grams)
K. Sample Collection:
1. Solid Samples should be collected in sterile bags. Liquid samples
should be collected in clean, leak proof, sterile screw cap containers.
2. Part 503 suggests that a geometric mean of a minimum of 7 grab
samples taken over a 14 day period is adequate for sampling of biosolids.
3. Collect 1 liter of compost, wastewater, or sludge in accordance with
Practice D 1066, Specification D 1192, and Practices D 3370, as
applicable.
L. Handling & Preservation:
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1. Sample transport to laboratories should be on ice and refrigerated. Do
not freeze samples. Samples not analyzed promptly should be stored at 04 degrees C and analyzed within 24 hrs.
2. Always keep copies of all data sheets from analysis of the sample in
your log book. Be sure to sign each copy.
M. Sample Preparation and Analysis:
1. Initial Preparation
A. For dry or thick samples, weigh 50 grams and place in 450 ml
RO water in a beaker and let soak overnight at 4-10 EC.
B. Transfer to a blender and blend at high for one minute.
2. For liquid samples measure 450 ml sample blend at high speed for one
minute.
3. Pour homogenized sample into one liter beaker and using
wash bottle, thoroughly rinse blender container into beaker. Add
200 ml 1% 7X Limbro
4. Allow sample to settle overnight at 4-10 EC. Stir
occasionally with a wooden applicator, as needed to ensure that material
floating on the surface settles. Additional 1% 7X Limbro may be added
and the mixture stirred if necessary.
5. Vacuum aspirate supemate to just above the layer of solids. Transfer
sediment to blender and add 200 ml RO water. Blend again for one
minute.
6. Transfer blended sample to beaker and rinse blender. Add 200 ml 1%
7X Limbro . Allow to settle for overnight at 4-10 EC.
7. Vacuum aspirate supemate to just above the layer of solids.
8. Add 200 ml 1% 7X Limbro and stir for 5 minutes on a magnetic stirrer.
9. Strain sample through 50- mesh tyler sieve placed in a funnel over a tall
beaker and add 100 ml 1% 7X Limbro. Wash sample through sieve with a
spray of 1% 7X Limbro from a spray bottle. Allow sample to settle
overnight at 4C.
10.Vacuum supemate to just above layer of solids. Mix sediment and
distribute equally to 250 ml bottles. Wash sediment from beaker into
bottles with RO water from a wash bottle.
12. Centrifuge for 3 minutes at 1250 rpm (400g) at 4EC with no brake..
Pour off supemate to above the level of sediment.
13. Resuspend the pellet in MgS0 4 solution in al:l ratio to yield a layer of
ova. Centrifuge immediately for 3minutes at 1250 rpm. DO NOT USE
BRAKE.
14. Pour supemate into 250 ml centrifuge bottles and dilute to at least 2
the concentration with RO water. Allow to settle overnight while ova
float to the surface. Do not disrupt flotation during this time.
15. Carefully decant supemate which contains ova if present and
centrifuge in 250 ml centrifuge bottle(s).
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16. Centrifuge the tubes for 3 minutes at 1400 rpm with no brake. Discard
supemate.
17. Aspirate supemate and resuspend pellet in 4 ml 0. IN H2SO4.18. Add 4 drops of surfactant Cap and mix the contents thoroughly by
■shaking several times.
19. Insert plastic filtering device into top of 15 ml centrifuge tube. Pour
fecal suspension through filtering device into the centrifuge tube.
20. Discard filtering device. Bring volume to tube up to 15 ml with RO
water and centrifuge at 500 xg (1800-2000 rpm) for 2 minutes.
21. Decant supernatant and retain the sediment. Resuspend the sediment
in 9ml ofRO water.
22. Add approximately 3ml ethyl acetate. Cap the tube and shake for 30
seconds inverting the tube while shaking. CAUTION: pressure may
build up with the tube during shaking. Carefully release the pressure
by opening the cap on the centrifuge tube away from your person
under the fume hood.
23. Centrifuge the tube at 500 xg (1800-2000 rpm) for 2 minutes.
Examination of the tube after centrifugation should reveal four distince
layers from the top:
1. A layer consisting of ethyl acetate
2. A plug of fecal debris
3. A discolored aqueous layer
4. A sediment layer containing the parasites
24. Hold the tube in a vertical position. Free the plug of debris by ringing
with a wooden cotton swab. Decant the upper layers leaving the sediment.
DO NOT TURN THE TUBE UPRIGHT UNTIL THE SIDES OF
THE TUBE HAVE BEEN CLEANED WITH THE COTTON TIP
SWABS.
25. Resuspend the sediment in 1 ml RO water. Place suspension on
Sedgwick Rafter counting chamber. Read for presence of Ascaris ova.
If none are present, report no viable helminth ova seen. If Ascaris ova are
recovered, proceed with step 26
26. Mark liquid level on each tube and incubate along with control vials
containing Ascaris ova mixed with 4 ml 0.1 N H2 SO4 at 26EC for 3-4
weeks. Check liquid level every 1-2 days and add RO water up to the
initial liquid level line as needed.
27. Examine the concentrates microscopically using a Sedgwick-Rafter
cell to enumerate the detected ova. Classify ova as either unembryonated,
embryonated to the first, second or third larval stage, (see attached figures
1-6 )
28. Appendix A. shows pictures of the three ova mentioned in this
procedure and some pseudo parasites and pitfalls that might be seen
during examination. These pictures should be used routinely to aid in
examining samples.
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O. Calculations:
1. Calculate % Total Solids using the % moisture result.
% Total Solids = 100% - % moisture
2. Calculate categories of ova/g dry weight in the following manner
Ova/g dry wt =

(NO) x (CV) x (FV)
(SP) x (TS)

Where:
NO = Number of ova
CV = Chamber volume (=1 ml)
FV = Final Volume in ml
SP = Sample processed in ml or grams
TS = % Total Solids
P. Records Management:
1. All records for all sludges are kept in a log book by date.
2. Report the results as the total number of Ascaris ova, number of
unembryonated Ascaris ova, number of 1st, 2nd, or 3rd stage larva; reported
as number of Ascaris ova and number of various larval Ascaris ova per
gram dry weight.
Q. Waste Management: All laboratory waste is sterilized prior to disposal.

II. Quality Control and Quality Assurance
A. Quality Control:
1. Calibration:
a. Balance is calibrated with NIST weights (1,10,100 grams) every
month.
b. Thermometer is calibrated with NIST thermometer every six
months.
c. Check temperatures in incubator daily and record in log book.
d. Centrifuge is calibrated according to procedures outlined in the
Lab Administration text
2. Obtain reference parasites from qualified outside sources. Tropical
Biologicals for Ascaris ova and Dr. Widmer Giovanni at Tufts Veterinary
School for Cryptosporidium parvum and Giardia Iambiia
3. Run one positive control with each batch of samples.
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B. Quality Assurance:
I. The minimum requirements of a formal quality assurance (QA)
program consist of an initial demonstration of laboratory capability
through the analysis of positive and negative control samples and blanks,
and analysis of positive and negative control samples and blanks as tests
of continued performance.

EDLReferences:
1) Intestinal Helminths. 1991 .Manual of Clinical Microbiology. 5th
Edition. Chapter 71.
2) Helminth Ova in Sewage Sludges, Environmental Regulations and
Technology: Control o f Pathogens and Vector Attraction in Biosolid. 1999
EPA-625-R-92-013. Office of Research and Development. USEPA.
3) Berk, SG., Gunderson. Wastewater Organisms A Color Atlas,1993.
4) Schmidt, Gerald D., Larry S. Roberts. Foundations o f Parasitology. 5th
Edition.
5) University of New Hampshire Microbiology Lab Safety Manual, 1998.

6) University o f New Hampshire Microbiology Quality Assurance Manual,
1998.
7) Yanko,WA., Occurrence o f Pathogens Distribution and Marketing
Municipal Sludges, EPA-600-I-87-014, USEPA, 1988
8) Garcia, Lynne S., David A. Bruckner. Diagnostic Medical
Parasitology. 3rd Edition.
9) Appendix I Analytical Method for Viable Helminth Ova. December
1992. USEPA. (* Updated version of #2*)
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Appendix A Identification of Helminth Ova

Helminth

Ova Size

Shell

Color

Char.

Worm

Ascaris
lumbricoides

55-75 um L
35-50 um W

Thick Shell
Bumpy layer

Transparent

Outer Bumpy
layer

Large
Round

Trichuris
trichiura

50-55 um L
22-24 um W

Thick Shell
Aplugs@

Yellow
Brown

Barrel shaped

Whip Worm

Toxocara
canis

75-85 um L
60-75 um W

Shelled
spherical

Brownish

surface
pits

Small
Round

Toxocara

75-85 um L
60-75 um W

Shelled
spherical

Brownish

cati

surface
pits

Small
Round

Hymenolepis
norm

20-60 um L
30-47 um W

Thin Shell
spherical

Yellow
Brown

Thickenings at
ends

Tape Worm
Smallest

Hymenolepis

70-85 um L
60-80 um W

Thick Shell
sphereical

Yellow
Brown

Larger than

Tape Worm
Smallest

diminuta

nana
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Appendix B
Procedure for Cryptosporidium Excystation:
(Robertson et al Parasitology 1993 (196) pp. 13-19)
Reagents: ^Reagents should be made freshly (<30 minutes before use)
-Bile Solution: 1% bovine bile in Hank’s minimal essential medium (HMEM)
-Sodium Hydrogen Carbonate Solution: 0.44% sodium hydrogen carbonate in RO water
Procedure:
1. Add 200 h1of bile solution and 50 «1 of sodium hydrogen carbonate solution to 100 til of purified
oocysts
2. Mix reactants gently and incubate at 37C for 4 hours
Enumeration of excystation percentages:
For each enumeration or time point, at least 100 oocysts should be counted and this should be
performed in duplicate. The percentage excystation is calculated as follows:
No. of ghosts ('totally excvstedl + No. of partly excvsted oocysts
Total no. of oocysts counted

xlOO

Count at a magnification of x400 by using differential interference microscopy.
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University of New Hampshire

Dynal Immunomagnetic Separation (Dynabeads GC-Combo)

April 7,2000
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Administrator; Dr. Aaron B. Margolin

Lab Manager: Nicola A. Ballester
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Lab Manager: Nicola A. Ballester

Date: July 14,2000

I. Procedural Section:
A. Scope & Applicability: This method is used for rapid, selective separation of
Giardia cysts and Cryptosporidium oocysts from water sample concentrates using
immunomagnetic separation (IMS). The method replaces flotation techniques
currently used for separating cysts and oocysts from other debris in water sample
concentrates.
B. Summary of Method: Dynabeads mti-Cryptosporidiwn and Dynabeads antiGiardia are incubated with the water sample concentrate along with SL-Buffer.
The antibodies coated on the beads will selectively bind cysts and/or oocysts
within the water sample concentrate and form a complex. The Dynabeadsorganism complexes are separated using a Dynal® magnetic particle concentrator
(Dynal® MFC) and subsequently the cysts and oocysts are dissociated from the
beads. The resultant suspension for screening will be clean and of a small
volume (approximately 50 pi).
C. Definitions:
1. Giardia: A genus containing flagellate protozoan organisms, including
Giardia Iambiia. The organism exists in a trophozoite (9-21 pm in length
and 5-15 pm in width) and a cyst form and targets the intestinal tract
manifesting as diarrhea, cramping and greasy stools.
2. Cryptosporidia: Small obligate, intracellular parasites that infect the
intestinal tract of a wide range of mammal s and range in size from 2-6pm.
The species infecting humans and cattle is referred to as Cryptosporidium
parvum. The principal route of infection is the fecal-oral transmission and
infective oocysts are excreted in stool. Clinical manifestations include
explosive, self-limiting diarrhea in immunocompetent individuals
D. Safety Warnings:
1. The Analyst must know and observe normal safety procedures and
proper handling should be followed closely when working with protozoan
parasite samples. Mouth -pipetting is prohibited.
2. Standard laboratory protective clothing must be worn
3. 0.02% sodium azide is used as a preservative in this product. Flush
with large volumes of water to prevent build-up of azide in plumbing.
E. Cautions: Field and laboratory staff collecting and analyzing environmental
samples are under some risk of exposure to pathogenic microorganisms. Staff
should apply safety procedures used for pathogens to handle all samples.
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F. Inferences:
1. Numerous transfers of the sample to new vessels may decrease the
recovery of ova.
2. Under microscopic examination, interfering debris such as: pollen,
starch, plant hairs, and vegetable material may interfere with reading
of the sample (Figure 1).
3. Cysts and oocysts must be washed twice in PBS/Tween followed by
once in demineralized water before seeding experiments are
conducted.
4. Kit and reagents must be brought to room temperature before use.
5. Vortex only for dissociation and not after the capture processes.
6. The use of vacuum aspirators has been shown to significantly reduce
the recovery.
7. Resuspend the Dynabeads before use to obtain a homogenous
suspension of beads in suspension. Shake SL-Buffer A and B before
use.
8. Precautions should be taken to prevent bacterial contamination of
opened vials.

G. Personnel Qualifications:
1. Laboratory Analyst/Technician: should have a B.S. and/or at least 1
year training in working with wastewater. Technicians should be well
versed in safety as well as proper handling of wastewater samples both
semisolid and fluid. The analyst must also demonstrate acceptable
performance during an on-site evaluation.
2. Any laboratory skilled, equipped, and/or certified for Giardia and
Cryptosporidium testing on water and environmental samples may use
Dynabeads® GC-Combo. The user must be skilled in using
conventional techniques and interpreting results. A user who is
proficient in recognition of Giardia cysts and Cryptosporidium oocysts
must perform screening of slides for enumeration of separated oocysts.
H. Apparatus & Materials:
1. Automatic Pipette, with filter
2. Binocular light microscope with 10X, 40X, 100X objectives
3. Oil Immersion
4. Gloves
5. Autoclave
6. Slides and Cover slips
7. Dynal Spot-on well microscopy slides
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8 . Sedgwick-Rafter cell

9. Small test tube rack to accommodate Dynal® tubes
10. Microfuge tube rack
11. 1.5 ml microfuge tubes
12. Dynal® Magnetic particle concentrator MPC
. 13. Dynal® L10 tubes
14. Dynal® rotating mixer
15. Vortex
16. (1) 15 ml conical tube
17. Micropipette (10-1000pl)
18. Fluorescence microscope
19. Demineralized cyst/oocysts free water
I. Reagents
1. Hydrochloric acid
2. Sodium hydroxide solution
3. Methanol
4. Fluorescein isothiocyanate (FITC) conjugated anti-Cryptosporidium
and anti-Giardia monoclonal antibody.
5. 4'6 diamidino-2-phenyl indole (DAPI)
6. DABCO/glycerol mounting medium
7. Dulbecco’s Phosphate Buffered Water (Sigma # D5652)
8. Giardia and Cryptosporidium positive control
9. Dynabeads® anti-Cryptosporidium and Dynabeads® anti-Giardia
These two reagents are uniform, monodisperse, and paramagnetic,
microscopic beads with purified antibodies against Cryptosporidium
oocysts and Giardia cysts covalently bound to the surface. The beads
are supplied as a suspension in phosphate buffered saline (PBS), pH
7.4 with 0.1% bovine serum albumin (BSA).
10. 10X SL-Buffer A (clear, colorless solution) and 10X SL-Buffer B
(magenta solution). This is a two component buffer system which has
been specifically designed to enable efficient separation of both
Giardia
cysts and Cryptosporidium oocysts to occur from a wide range of
water types. Buffers are stable when stored unopened at 2-8°C until
the expiration date stated.
J. Instrumentation and Methods of Calibration:
1. Centrifuge is calibrated according to procedures outlined in the Lab
Administration text.

K. Sample Collection:
1. The water sample concentrates can be of any treated water or
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2.
3.
4.

5.

untreated (Raw) water which is intended for potable supply
Water sample concentrates should be prepared by standard filtration
and centrifugation methods.
The quantity of particulate matter in each sample should be such that
the packet pellet volume is 5% or less.
Following centrifugation at a minimum of 1050g for 10 min carefully
remove all the supernatant. Add reagent grade water so that the final
volume does not contain more that 0.5 ml packet pellet (measured
following centrifugation) per 5 ml. If final volume is greater than 5 ml
the sample must be subdivided with each aliquot not exceeding 5 ml.
If the sample is suspended in eluting detergents or preserving solutions
then it should be resuspended in water.

L. Handling & Preservation:
1. Samples not analyzed promptly should be stored at 0-4 degrees C and
analyzed within 24 hrs.
2. Always keep copies of all data sheets from analysis of the sample in
your log book. Be sure to sign each copy.
M. Sample Preparation and Analysis:
1. Obtain a flat-sided Dynal® (L10) tube.
2. Add 500 pi of 10X SL Buffer A and 500pl of 10X SL Buffer B to the
Dynal® (L10) tube.
3. Immediately transfer 5 ml of water sample to the Dynal® (L10) tube
containing the buffer.
4. Vortex Dynabeads® anti-Cryptosporidium to fully Resuspend.
5. Add 50 pi of Dynabeads® anti-Cryptosporidium to the Dynal® tube
containing the sample.
6. Vortex Dynabeads® anti-Giardia to fully Resuspend.
7. Add 50pl to the Dynal® (L10) tube containing the sample.
8. Affix the Dynal® (LI0) tube to a Dynal® rotating mixer and rotate 1520 rpm for 1 hour at room temperature.
db
9. Following incubation remove tube from mixer and place in a Dynal
MPC-1 with the flat side towards the magnet
10. Without moving the tube from the Dynal® MPC-1, place magnet side
downwards and gently rock tube for 2 minutes.
11. Return tube to the upright position and decant supernatant while tube
is in the concentrater.
12. Remove the tube from the concentrater and add 500pl of IX SL buffer
A and mix gently. DO NOT VORTEX!
13. Transfer the liquid to a 1.5 ml microcentrifuge tube.
14. Place the microcentrifuge tube into a Dynal® MPC-S
15. Gently rock the tube for 1 minute with one rock per second
16. Remove supernatant from the tube while held in the MPC-S. DO NOT
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SHAKE TUBE!
17. Remove magnetic strip from Dynal® MPC-S
18. Add 50jxl of 0.1 N HCL to the microcentrifiige tube and vortex
thoroughly for 10 seconds.
19. Place tube in MPC-S without magnet and allow to stand 10 minutes at
room temperature.
20. Vortex thoroughly for 10 seconds.
21. Ensure all sample is at the base of the tube and place in MPC-S.
22. Allow tubes to stand undisturbed for 10 seconds.
23. Prepare Dynal® spot-on slide and air dry.
24. Scan slide with light microscope.
25. Appendix A. shows pictures of the two protozoans mentioned in this
procedure and some pseudo parasites and pitfalls that might be seen
during examination. These pictures should be used routinely to aid in
examining samples.
P. Records Management:
1. All records for all samples are kept in a log book by date.
2. Report the results as the total number of Cryptosporidium oocysts and
Giardia cysts seen during examination.

Q. Waste Management: All laboratory waste is sterilized prior to disposal.
II. Quality Control and Quality Assurance
A. Quality Control:
1. Calibration: Centrifuge is calibrated according to procedures outlined
in the Lab Administration text
2. Obtain reference parasites from qualified outside sources. Dr. Widmer
Giovanni at Tufts Veterinary School for Cryptosporidium parvum and
Giardia lamblia
3. Run one positive control and one negative control with each batch of
samples.
B. Quality Assurance:
1. The minimum requirements of a formal quality assurance (QA)
program consist of an initial demonstration of laboratory capability
through the analysis of positive and negative control samples and blanks,
and analysis of positive and negative control samples and blanks as tests
of continued performance.
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APPENDIX-D

University of New Hampshire

Merlfluor® C ryptospordium/Giardia
October 22,2003

Prepared by:

Christine L. Bean and Van Pham

Administrator: Dr. Aaron Margolin
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L Procedural Section
A. Scope & Applicability: This is an in vitro direct immunofluorescent detection
method for identification of Cryptosporidium oocysts and Giardia cysts in
biosolid samples.
B. Summary ofMethod: Merifluor is using the method of direct
immunofluorescence. The Detection reagent contains labeled monoclonal
antibodies directed against cell wall antigens of Cryptosporidium oocysts and
Giardia cysts. Once the sample from Dynal is treated with the Detection reagent
and a counterstain, the monoclonal antibodies attach to Cryptosporidium/Giardia
antigens present in the specimen. The slides are rinsed with buffer to wash off the
unbound antibodies. A cover slip is applied with a drop of mounting medium,
and the slide is examined under fluorescent microscopy for Cryptosporidium
oocysts with an apple green color. The background material in the specimen is
- stained dull orange to red color.
C. Definitions:
1. Cryptosporidia: Protozoan, obligate intracellular parasites that causes severe
diarrhea in humans worldwide. Cryptosporidium parvum is the species that
infecting humans and cattle. C. parvum causes potentially life-threatening disease
in people with AIDS or immunocompromise. This disease is transmitted via the
fecal-oral route.
2. Giardia: Flagellate protozoan organisms that include Giardia lamblia. The
disease condition cause by this organism is diarrhea, camping and greasy stools.
D. Safety Warning:
1. The analyst must know and observe normal safety procedures and proper
handling should be followed closely when working with protozoan parasite
samples. Mouth-pipetting is prohibited.
2. Standard laboratory protective clothing must be worn and avoid skin contact
with reagents
3. 0.02% sodium azide is used as a preservative in this product. Flush with large
volumes of water to prevent build-up of azide in plumbing.
E. Cautions:
Field and laboratory staff collecting and analyzing environmental samples are
under some risk of exposure to pathogenic microorganisms. Staff should apply
safety procedures used for pathogens to handle all samples.
F. Inferences:
1. False negative results could be due to vigorous wash procedure or insufficient
specimen drying time.
2. Reagent kits must be brought to room temperature before use.
3. Protect the Detecting reagent and Counterstain from exposure to light.
4. Mix all the reagents well before use.
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5. Do not scratch the slide when mixing reagents.
6. Keep the slide moist when incubating.
7. Use reagents before outdate.
G. Personnel Qualifications:
1. Laboratory Analyst/Technician: should have a B.S. and/or at
least 1 year training in working with wastewater. Technicians
should be well versed in safety as well as proper handling of
wastewater samples both semisolid and fluid. The analyst must
also demonstrate acceptable performance during an on-site
evaluation.
2. Any laboratory skilled, equipped, and/or certified for Giardia
and Cryptosporidium testing on water and environmental
samples may use Dynabeads® GC-Combo. The user must be
skilled in using conventional techniques and interpreting
results. A user who is proficient in recognition of Giardia
cysts and Cryptosporidium oocysts must perform screening of
slides for enumeration of separated oocysts.

H. Apparatus & Material:
- Applicators
- Wash bottles
- Humidity chamber
- Microscope slide coverslips
- Gloves
- Autoclave
- Fluorescent microscope
I. Reagent:
- FITC labeled anti-Cryptosporidium and mti-Giardia monoclonal antibodies
containing a protein stabilizer and 0.1% sodium azide.
- Eriochrome Black solution
- Buffer
- Buffered glycerol containing formalin, an antiquencher and 0.05% sodium
azide.
J. Instrumentation and Methods of Calibration:
Fluorescent microscope in the Microbiology Department is used for evaluating
test results. Please see Robert Mooney to set up the microscope.
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K. Sample Collection:
1.
The water sample concentrates can be of any treated water or untreated
water which intended for potable supply
2.
Water sample concentrates should be prepared by standard filtration and
centrifugation methods.
L. Handling & Preservation:
1. Samples not analyzed should be stored at 0-4° C
2. Always keep copies of all data sheets from analysis of the sample in the log
book.
M. Sample Preparation and Analysis:
1. Transfer sample to a treated slide well and spread it evenly entire well. Do
not scratch the treated surface of the slide.
2. Add a drop of Positive Control to a separate treated slide well and spread it
evenly over the entire well.
3. Add a drop of Negative Control to a separate treated slide well and spread it
evenly throughout entire well.
4. Allow the slides to air dry at room temperature.
5. Place one drop of Detection Reagent in each well.
6. Place one drop of Counterstain in each well.
7. Mix the reagents with an applicator stick and spread over the entire well.
8. Incubate the slides in a humidified chamber for 30 minutes at room
temperature. Notes: Protect from light.
9. Rinse the slides with a gentle stream of IX Wash Buffer until excess
Detection Reagent and Counterstain is removed. Note: Do not submerge the
slides during rinsing.
10. Remove excess buffer by tapping the long edge of the slide on a clean paper
towel. Note: Do not allow slide to dry.
11. Add one drop of Mounting Medium to each well and apply a coverslip.
12. Seal the slide with nail polish and allow to air dry.
13. Scan each well thoroughly using fluorescent microscope.
N. Records Management:
1. All results of all samples are kept in a log book by date.
O. Waste Management: All laboratory waste is sterilized prior to disposal.
DL Quality Control and Quality Assurance
A. Quality control:
1. Calibration: Centrifuge is calibrated according to procedures outlined in
the Lab Administration text
2. Obtain reference parasites from qualified outside sources. Dr. Widmer
Giovanni at Tufts Veterinary School for Cryptosporidium parvum and
Giardia lamblia
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3. Run one positive control and one negative control with each batch of
samples.
B. Quality Assurance:
1. The minimum requirements of a formal quality assurance (QA) program
consist of an initial demonstration of laboratory capability through the
analysis of positive and negative control samples and blanks, and analysis of
positive and negative control samples and blanks as tests of continued
performance.
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APPENDIX E
Procedure for Viability Assay of Cryptosporidium using Fluorogenic Vital Dyes:
(Campbell et al AEM 1992 (58) pp. 3488-3493)
Reagents: *Prepare and store at 4C in the dark
-4, 6-diamidino-2-phenylindole (DAPI): Working solution ofDAPI is 2 mg/ml in
absolute methanol
-Propidium iodide (PI): Working solution ofPI is 1 mg/ml inO.l M PBS, pH 7.2
Procedure:
1. Add 10 pi ofDAPI working solution and 10 pi ofPI working solution to 100 pi of purified
oocysts suspension.
2. Mix reactants and incubate at 37C for 2 hours.
3. Wash oocysts twice in Hank’s Balanced Salt Solution before viewing by epifluorescence
microscopy.
Microscopy:
For each sample time point read, ten pi aliquots of oocysts suspension is viewed under both DIC
(Nomarski) optics and epifluorescence with and Olympus BH2 microscope equipped with a UV
filter block (3.50-nm excitation, 450-nm emission) for DAPI and a green filter block (500-nm
excitation, 630-nm emission) for PI. Proportions of ruptured (ghost), Pi-positive (PI+), DAPInegative Pi-negative (DAPI-PI-) and DAPI-positive Pi-negative (DAPI+PI-) is quantified by
enumerating 100 oocysts in duplicate for each time point sample.
Identification:
1.

Ghost oocysts: ruptured oocysts, which can by identified under Nomarski optics
PI+: oocysts fluoresce bright red under the green filter block (red fluorescence varies in intensity
depending on where the sporozoite nuclei are located)
3. DAPI+PI-: No inclusion of PI and nuclei of sporozoites fluoresce sky blue under UV filter block
4. DAPI-PI-: No inclusion of PI, not ghosts, shows a rim of fluorescence or an absence of
fluorescence under the UV filter block.
2.
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APPENDIX F
Procedure to Viability Assay of Giardia lamblia using Fluorogenic Vital Dyes:
(Sctiupp et al AEM 1987 (53) pp. 704-707
Reagents: * Prepare and store at 4C in the dark
-Fluorescein diacetate (FDA): Stock solution of FDA is 10 mg FDA in 1ml
acetone
Working solution is 0.04ml stock mixed with 10ml Dulbecco PBS at pH 7
-Propidium iodide (PI): Stock solution of PI is 0.5mg PI mixed with 50 ml
Dulbecco PBS pH 7

Procedure:
1. 4ug of FDA per 106 cysts or 3 ug of PI per 106 cysts
2. Cysts are stained for 5 minutes
3. Observe microscopically with Olympus BH-2 epifluorescence microscope at
excitation wavelengths of 455 to 490 nm for FDA and 545 to 546 nm for PI.

Identification:
FDA+ (intense green) Viable cysts
PI+ (bright orange at 450-490 nm with excitation barrier filter combination)
(bright red at 545 to 546 nm) Nonviable cysts
FDA-PI- (appear black- nonstaining cysts) interpreted as a subpopulation of
FDA+ cysts

Principle of dyes:
FDA: An intact lipid bilayer slows leakage of the fluorochrome from within
intact cells while injured cells cannot retain or accumulate the fluorochrome. In
viable G. lamblia cysts, both the lipid membrane of the cell and the cyst wall may
serve as barriers to the diffusion of fluorescein, whereas damaged or nonviable
cysts may not accumulate fluorescein due to the presence of rupture membranes.
PI: has not been shown to transverse intact cell membranes; therefore, only cells
with disrupted or broken membranes are counterstained by PI. The fluorochrome
is specific for DS nucleic acids
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APPENDIX G
IACUC Approval Forms
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Service Building
51 College Road
D urham , New H am pshire 03824-3585
(603) 862-3564 FAX
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LAST NAME

FIRST NAM E
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Medical ^Laboratory Science Program, 277Hewitt®4fl

NEXT REV IEW
DATE '
•

6/26/2004'

OFF-CAMPUS
ADDRESS

Medical Laboratory Science Program
277 Hewitt Hall , ;

IA CU C #

020607

(if applicable)

PR O JE C T
TIT L E

;u-'

R EV IE W LEV EL

P

DATE O F N O TIC E

6/>l/2003' ;

Propagation, o f Cryptosporidium in M ice

The Institutional Animal Care and Use Committee (IACUC) has reviewed and approved your request for a time extension for
this protocol. Approval is granted until the “Next Review Date” indicated above. You will be asked to submit a project
report with regard to the involvement o f animals before that date. If your project is still active, you may apply for extension of
IACUC approval through this office.
The appropriate use and care o f animals in your project is an ongoing process for which you hold primary responsibility.
Changes in your protocol must be submitted to the IACUC for review and approval prior to their implementation. If you have
questions or concerns about your project or this approval, please feel free to contact the Regulatory Compliance Office at
862-2003 or 862-3536.
Please note: Use of animals in research and instruction is approved contingent upon participation in the UNH Occupational
Health Program for persons handling animals. Participation is mandatory for all principal investigators and their affiliated
personnel, employees o f the University and students alike. A Medical History Questionnaire accompanies this approval; please
copy and distribute to all listed project staff who have not completed this form already. Completed questionnaires should be
sent to Dr. Gladi Porsche, UNH Health Services.
Please refer to the IACUC # above in all correspondence related to this project The IACUC wishes you success with your
research.
J o r the IACUC,

U

'Ohn
n A. Litvaitis, Ph.D.
Chair

cc:

File

OR1G A PP’L

6/26/2002

Dr. Giovanni Widmer, Tufts
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D A TE O F N O TIC E

6/11/2003

Efficacy o f 2BA092 and derivatives against Giardia

The Institutional Animal Care and Use Committee (IACUC) has reviewed and approved your request for a time extension for
this protocol. Approval is granted until the “Next Review Date” indicated above. You will be asked to submit a project
report with regard to the involvement of animals before that date. If your project is still active, you may apply for extension of
IACUC approval through this office.
The appropriate use and care o f animals in your project is an ongoing process for which you hold primary responsibility.
Changes in your protocol must be submitted to the IACUC for review and approval prior to their implementation. I f you have
questions o r concerns about your project or this approval, please feel free la contact the Regulatory Compliance Office at
862-2003 or 862-3536.
Please note; Use of animals in research and instruction is approved contingent upon participation in the UNH Occupational
Health Program for persons handling animals. Participation is mandatory for all principalin vest? gators and theif affiliated
personnel, employees o f the University and students alike. A Medical History Questionnaire accompanies this approval; please
copy and distribute to all listed project staff who have not completed this form already. Completed questionnaires should be
sent to Dr. Gladi Porsche, UNH Health Services.
Please refer to the IACUC # above in all correspondence related to this project. The IACUC wishes you success with your
research.
For the IACUC,
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\J p h n A. Litvaifcis, Ph.D.
Chair

cc:
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Dr. Giovanni Widmer, Tufts
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